• ÁøÇ༺ ÆíÆò»óÇǼ¼Æ÷Æó¾Ï¿¡ ´ëÇÑ Ä¡·á

• Treatment of Advanced and Metastatic Squamous Non-small Cell Lung Cancer

• Á¶Àº°æ:Cho Eun-Kyung ÀúÀÚ¾øÀ½:No authors listed

• ´ëÇѳ»°úÇÐȸÁö  2016³â 90±Ç 1È£ 1~6

• Á¾ÇÕ°¨±â¾à º¹¿ë ÈÄ ¹ß»ýÇÑ ¾ç¾È ±Þ¼º Æó¼â°¢¹ßÀÛ 1¿¹

• A Case of Bilateral Acute Angle Closure Attack Induced by Common Cold Medication

• È«ÀºÈñ(Hong Eun-Hee) À̹ÎÁö(Lee Min-Jee) ¼ÛÀμ®(Song In-Suk)

• ´ëÇѾȰúÇÐȸÁö  2016³â 57±Ç 2È£ 334~340

• Concomitance of P-gp/LRP Expression with EGFR Mutations in Exons 19 and 21 in Non-Small Cell Lung Cancers

• (Wei Hong) (Lu Weipeng) (Li Mei) (Zhang Qiuping) (Lu Shen)

• Yonsei Medical Journal  2016³â 57±Ç 1È£ 50~57

• Pazopanib for Non-small Cell Lung Cancer: The First Case Report in Korea

• Á¶Àç¹Î(Jo Jae-Min) ±èÁ¤È£(Kim Jung-Ho) ±èÁö¿µ(Kim Ji-Young) Çö⸲(Hyun Chang-Lim) ÀÌÁö¿µ(Rhee Ji-Young) ±ÇÁ¤¹Ì(Kwon Jung-Mi) ÇÑ»óÈÆ(Han Sang-Hoon) ±è¿ì°Ç(Kim Woo-Kun)

• Cancer Research and Treatment  2016³â 48±Ç 1È£ 393~397

• Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

• ³ëÀç¸í(Noh Jae-Myoung) ±èÁø¸¸(Kim Jin-Man) ¾È¿ëÂù(Ahn Yong-Chan) ǥȫ·Ä(Pyo Hong-Ryull) ±èº¸°æ(Kim Bo-Kyong) ¿Àµ¿·Ä(Oh Dong-Ryul) ÁÖ»ó±Ô(Ju Sang-Gyu) ±èÁø¼º(Kim Jin-Sung) ½ÅÁ¤¼®(Shin Jung-Suk) ȫä¼±(Hong Chae-Seon) ¹ÚÈ¿Á¤(Park Hyo-Jung) ÀÌ¿ÂÁÖ(Lee Eon-Ju)

• Cancer Research and Treatment  2016³â 48±Ç 1È£ 106~114

• Predictors of Recurrence after Curative Resection in Patients with Early-Stage Non-Small Cell Lung Cancer

• ÀÌ»óÈñ(Lee Sang-Hee) Á¶ÀºÁ¤(Jo Eun-Jung) ¾öÁß¼·(Eom Jung-Seop) ¸ñÁ¤ÇÏ(Mok Jeong-Ha) ±è¹ÌÇö(Kim Mi-Hyun) À̱¤ÇÏ(Lee Kwang-Ha) ±è±â¿í(Kim Ki-Uk) ¹ÚÇý°æ(Park Hye-Kyung) ÀÌâÈÆ(Lee Chang-Hun) ±è¿µ´ë(Kim Yeong-Dae) À̹αâ(Lee Min-Ki)

• °áÇÙ¹×È£Èí±âÁúȯ  2015³â 78±Ç 4È£ 341~348

• The Prognostic Value of the Tumor Shrinkage Rate for Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Receiving Gefitinib

• ¹Úµ¿ÀÏ(Park Dong-Il) ±è¼±¿µ(Kim Sun-Young) ±èÁÖ¿Á(Kim Ju-Ock) ¹ÚÈñ¼±(Park Hee-Sun) ¹®À翵(Moon Jae-Young) Á¤Àç¿í(Chung Chae-Uk) ±è¼º¼ö(Kim Song-Soo) ¼­ÀçÈñ(Seo Jae-Hee) ÀÌÁ¤Àº(Lee Jeong-Eun) Á¤¼º¼ö(Jung Sung-Soo)

• °áÇÙ¹×È£Èí±âÁúȯ  2015³â 78±Ç 4È£ 315~320

• The Efficacy of Postoperative Chemotherapy for Patients with Metastatic Brain Tumors from Non-Small Cell Lung Cancer

• (Hong Noah) ÁÖÁ¤³²(Joo Jung-Nam) ½Å»óÈÆ(Shin Sang-Hoon) °ûÈ£½Å(Gwak Ho-Shin) À̼ºÈÆ(Lee Seung-Hoon) À¯Çå(Yoo Heon)

• Brain Tumor Research and Treatment  2015³â 3±Ç 2È£ 108~114

• ÁøÇ༺ ³ëÀÎ Æó¾Ï¿¡ ´ëÇÑ Ç׾Ͽä¹ý

• Anti-Cancer Therapy of Advanced Lung Cancer in Elderly Patients

• ¹Î¿µÁÖ(Min Young-Joo)

• ´ëÇѳ»°úÇÐȸÁö  2014³â 87±Ç 5È£ 537~541

• Immunotherapy for Non-Small Cell Lung Cancer

• À±¼ºÈ£(Yoon Sung-Ho)

• °áÇÙ¹×È£Èí±âÁúȯ  2014³â 77±Ç 3È£ 111~115

• Outcomes of Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer in One Institution

• À̼®Á¤(Lee Seok-Jeong) °­ÇöÁÖ(Kang Hyun-Ju) ±è¼­¿ì(Kim Seo-Woo) (Ryu You-Ju) ÀÌÁøÈ­(Lee Jin-Hwa) ±èÀ¯°æ(Kim Yoo-Kyung) ÀåÁßÇö(Chang Jung-Hyun)

• °áÇÙ¹×È£Èí±âÁúȯ  2014³â 77±Ç 1È£ 13~17

• Long Term Therapeutic Plan for Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutation

• Àå½ÂÈÆ(Jang Seung-Hun)

• °áÇÙ¹×È£Èí±âÁúȯ  2014³â 76±Ç 1È£ 8~14

• Update on the Evidence Regarding Maintenance Therapy

• ÀÌÁ¤Àº(Lee Jeong-Eun) Á¤Àç¿í(Chung Chae-Uk)

• °áÇÙ¹×È£Èí±âÁúȯ  2014³â 76±Ç 1È£ 1~7

• The Prognosis According to Patterns of Mediastinal Lymph Node Metastasis in Pathologic Stage IIIA/N2 Non-Small Cell Lung Cancer

• ±èµµ¿Ï(Kim Do-Wan) À±ÁÖ½Ä(Yun Ju-Sik) ¼Û»óÀ±(Song Sang-Yun) ³ª±¹ÁÖ(Na Kook-Joo)

• ´ëÇÑÈäºÎ¿Ü°úÇÐȸÁö  2014³â 47±Ç 1È£ 13~19

• EGFR µ¹¿¬º¯ÀÌ¿Í ROS1 ÀüÀ§¸¦ µ¿½Ã¿¡ °¡Áø Æó¼±¾Ï È¯ÀÚÀÇ Erlotinib Ä¡·á 1¿¹

• A Favorable Treatment Response of Erlotinib in Lung Adenocarcinoma with Concomitant Activating EGFR Mutation and ROS1 Rearrangement

• ±è¹Îȯ(Kim Min-Hwan) ¹Ú¿¹Çö(Park Ye-Hyun) ¹ÚÇýÁ¤(Park Hye-Jung) Áö¾Æ¿µ(Ji Ah-Young) ¼Ûâȣ(Song Chang-Ho) Áø¹«³â(Jin Moo-Nyun) ±è¿µÁÖ(Kim Young-Ju) ±è¼±¿í(Kim Sun-Wook) ÀÌÁßÈñ(Lee Jung-Hee) ±èÀμö(Kim In-Soo) ±èÇý·Ã(Kim Hye-Ryun) ±èÁÖÇ×(Kim Joo-Hang) Á¶º´Ã¶(Cho Byoung-Chul)

• The Ewha Medical Journal  2014³â 37±Ç 1È£ 46~51

• ºñ¼Ò¼¼Æ÷Æó¾ÏÀÇ ¼¼Æ÷µ¶¼º Ç×¾ÏÈ­Çпä¹ý

• Cytotoxic Chemotherapy for Non-small Cell Lung Cancer

• ¹Úº´¹è(Park Byeong-Bae)

• Hanyang Medical Reviews  2014³â 34±Ç 1È£ 31~36

• Æó¾Ï ȯÀÚ¿¡ ´ëÇÑ ºÎ°¡ÀûÀΠħġ·á È¿°ú - ´ÜÀϱº, ÀüÈÄ, ¿¹ºñÀÓ»ó ¿¬±¸ -

• Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients - A single group before-and-after, preliminary study -

• ±èµµÇü(Kim Do-Hyung) ÀüµÎ¼ö(Jeon Doo-Soo) ¹Ú½ÂÂù(Park Seung-Chan) À̽ÂÀº(Lee Seung-Eun) Á¶¿ìÇö(Cho Woo-Hyun) ÇÑâ¿ì(Han Chang-Woo) ±è¼Ò¿¬(Kim So-Yeon) ÃÖÁØ¿ë(Choi Jun-Yong) ±èÀ±¼º(Kim Yun-Seong)

• µ¿ÀÇ»ý¸®º´¸®ÇÐȸÁö  2014³â 28±Ç 1È£ 82~88

• Reversal of Cisplatin Resistance by Epigallocatechin Gallate Is Mediated by Downregulation of Axl and Tyro 3 Expression in Human Lung Cancer Cells

• ±è°æÂù(Kim Kyung-Chan) ÀÌÃßÈñ(Lee Chu-Hee)

• Korean Journal of Physiology & Pharmacology  2014³â 18±Ç 1È£ 61~66

• Clinical Features and Prognostic Factors in Elderly Koreans with Advanced Non-Small-Cell Lung Cancer in a Tertiary Referral Hospital

• ±è¼­¿ì(Kim Seo-Woo) ±è¹Ì¿¬(Kim Mi-Yeon) ÀÌÀ±Ç¥(Lee Yoon-Pyo) ·ù¿¬ÁÖ(Ryu Yon-Ju) À̼®Á¤(Lee Seok-Jeong) ÀÌÁøÈ­(Lee Jin-Hwa) ÀåÁßÇö(Chang Jung-Hyun) ½É¼º½Å(Shim Sung-Shine)

• °áÇÙ¹×È£Èí±âÁúȯ  2013³â 75±Ç 2È£ 52~58

• Clinical Implications of VEGF, TGF-¥â1, and IL-1¥â in Patients with Advanced Non-small Cell Lung Cancer

• ±èÁö¿ø(Kim Ji-Won) °í¿µÀÏ(Koh Young-Il) ±èµ¿¿Ï(Kim Dong-Wan) ¾È¿ë¿î(Ahn Yong-Oon) ±èŹÎ(Kim Tae-MIn) ÇѼ¼¿ø(Han Sae-Won) ¿Àµµ¿¬(Oh Do-Youn) À̼¼ÈÆ(Lee Se-Hoon) ÀÓ¼®¾Æ(Im Seock-Ah) ±èÅÂÀ¯(Kim Tae-You) Çã´ë¼®(Heo Dae-Seog) ¹æ¿µÁÖ(Bang Yung-Jue)

• Cancer Research and Treatment  2013³â 45±Ç 4È£ 325~333

• Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung Cancer

• ±è°æÇö(Kim Kyeong-Hyun) ¼Û¼¼¿µ(Song Seo-Young) ÀÓ±ÔÇü(Lim Kyu-Hyoung) ÇѼ±¼÷(Han Seon-Sook) ±è¼¼Çö(Kim Se-Hyun) Á¶ÁØÈÖ(Cho Jun-Hwi) ¹ÚÂù¿ì(Park Chan-Woo) (Lee Seoung-Koo) ÀÌÈñ¿µ(Lee Hui-Young)

• Cancer Research and Treatment  2013³â 45±Ç 1È£ 74~77

• Secondary Prophylaxis of Docetaxel Induced Diarrhea with Loperamide: Case Report

• ÀÌÈñ¿¬(Lee Hee-Yeon) ÀÌÀ±Èñ(Lee Youn-Hee) ±è¹ÎÁö(Kim Min-Ji) ±èÈƱ³(Kim Hoon-Kyo)

• Journal of Korean Medical Science  2013³â 28±Ç 10È£ 1549~1551

• Transglutaminase 2 Expression Predicts Progression Free Survival in Non-Small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

• Á¤ÀçÇå(Jeong Jae-Heon) Á¶º´Ã¶(Cho Byoung-Chul) ½ÉÈ¿¼·(Shim Hyo-Sup) ±èÇý·Ã(Kim Hye-Ryun) ÀÓ¼±¹Î(Lim Sun-Min) ±è¼¼±Ô(Kim Se-Kyu) Á¤°æ¿µ(Chung Kyung-Young) (S.M. Bakhtiar Ul Islam) ¼ÛÀçÁø(Song Jae-Jin) ±è¼ö¿­(Kim Soo-Youl) ±èÁÖÇ×(Kim Joo-Hang)

• Journal of Korean Medical Science  2013³â 28±Ç 7È£ 1005~1014

• Æó¾Ï ȯÀÚ¿¡¼­ Docetaxel Ç×¾Ï ¿ä¹ý Ä¡·á ÈÄ ¹ß»ýÇÑ ÇǺΰæÈ­Áõ 1¿¹

• A Case of Skin Sclerosis Associated with Docetaxel Chemotherapy for Non-Small Cell Lung Cancer

• ³²ÀçÇü(Nam Jae-Hyung) ¹®Á¾ÁÖ(Moon Jong-Joo) ÀÌÁØÇõ(Lee June-Hyuk) ¹Ú¼º¿ì(Park Sung-Woo) Àå¾È¼ö(Jang An-Soo) ±èµµÁø(Kim Do-Jin) ÀüÂùÈ«(Jeon Chan-Hong) °íÀº¼®(Koh Eun-Seok)

• ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö  2013³â 20±Ç 3È£ 198~201

• Outcome of Surgical Resection of Symptomatic Cerebral Lesions in Non-Small Cell Lung Cancer Patients with Multiple Brain Metastases

• È«³ë¾Æ(Hong No-Ah) (Yoo Heon-Yoo) °ûÈ£½Å(Gwak Ho-Shin) ½Å»óÈÆ(Shin Sang-Hoon) À̼ºÈÆ(Lee Seung-Hoon)

• Brain Tumor Research and Treatment  2013³â 1±Ç 2È£ 64~70

• ºñ¼Ò¼¼Æ÷Æó¾ÏÀÇ º¸Á¶Ç×¾ÏÈ­Çпä¹ý

• Adjuvant Chemotherapy in Non-Small Cell Lung Cancer

• ±èµ¿¿Ï(Kim Dong-Wan)

• ´ëÇѳ»°úÇÐȸÁö  2012³â 83±Ç 3È£ 305~308

• ÀÓ»êºÎ¿¡¼­ ¹ß»ýÇÑ ¿ø¹ß¼º Æó¾Ï 1¿¹

• A 36 Year-Old Primivida Diagnosed with Primary Lung Cancer

• °í¼±Çý(Ko Sun-Hye) °­ÇöÈñ(Kang Hyeon-Hui) ÀÓ¼±¹Ì(Yim Sun-Mie) ȲÀ¯¹Ì(Hwang You-Mi) ÁöÀºÇý(Ji Eun-Hye) ¿ÀÀ¯¼®(Oh You-Suk) ÀÌ»óÇÐ(Lee Sang-Haak)

• ´ëÇѳ»°úÇÐȸÁö  2012³â 82±Ç 1È£ 85~89

• Second Complete Remission of Relapsed Stage IV Non-Small Cell Lung Cancer Following Retreatment

• À¯¼öÁø(Yoo Su-Jin) ÀÌÁ¤Àº(Lee Jeong-Eun) Á¤¼±¿µ(Jung Sun-Young) ¹Úµ¿ÀÏ(Park Dong-Il) ¹Ú¸í¸°(Park Myoung-Rin) ¹ÚÈñ¼±(Park Hee-Sun) Á¤¼º¼ö(Jung Sung-Soo) ±èÁÖ¿Á(Kim Ju-Ock) ±è¼±¿µ(Kim Sun-Young)

• °áÇÙ¹×È£Èí±âÁúȯ  2012³â 72±Ç 4È£ 381~385

• DNA-Damage Inducible 1 is a Property of Human Non-Small Cell Lung Cancer

• ÀÌÁö¿¬(Lee Ji-Yeon) °­Àº½Ç(Kang Eun-Sil) ÀÓ¹üÁø(Lim Beom-Jin) ÀåÀ±¼ö(Chang Yoon-Soo) ±è¼¼±Ô(Kim Se-Kyu)

• °áÇÙ¹×È£Èí±âÁúȯ  2012³â 72±Ç 2È£ 124~131

• Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer

• (Kim D. Nathan) ³²ÅñÙ(Nam Taek-Keun) (Choe Kevin S.) (Choy Hak)

• Cancer Research and Treatment  2012³â 44±Ç 2È£ 74~84

• Chemotherapy in Patients Older than or Equal to 75 Years with Advanced Non-small Cell Lung Cancer

• ±è½ÂÅÂ(Kim Seung-Tae) ¹Ú°æÈ­(Park Kyong-Hwa) ¿À»óö(Oh Sang-Cheul) ¼­ÀçÈ«(Seo Jae-Hong) ±èÁؼ®(Kim Jun-Suk) ±è¿­È«(Kim Yeul-Hong) ½Å»ó¿ø(Shin Sang-Won)

• Cancer Research and Treatment  2012³â 44±Ç 1È£ 37~42

• Concurrent chemoradiotherapy for elderly patients with stage III non-small cell lung cancer

• °­±â¹®(Kang Ki-Mun) Á¤¹è±Ç(Jeong Bae-Kwon) ÇÏÀκÀ(Ha In-Bong) ä±Ô¿µ(Chai Gyu-Young) ÀÌ°æ¿ø(Lee Gyeong-Won) ±èÈƱ¸(Kim Hoon-Gu) °­Á¤ÈÆ(Kang Jung-Hoon) ÀÌ¿ø¼·(Lee Won-Sup) °­¸íÈñ(Kang Myoung-Hee)

• Radiation Oncology Journal  2012³â 30±Ç 3È£ 140~145

• ¾Ë·¯Á¨ Á¦°Å ¿Ì³ª¹« ÃßÃâ¹° Åõ¿©·Î »ýÁ¸±â°£ÀÌ ¿¬ÀåµÈ 4±â ºñ¼Ò¼¼Æ÷¼ºÆó¾Ï ȯÀÚ 1·Ê

• A Case Report of a Patient with Advanced Non-Small Cell Lung Cancer Treated with Allergen Removed Rhus Verniciflua Stokes (aRVS)

• ÃÖ¼ºÇå(Choi Seong-Heon) ¼Û¾È³ª(Song An-Na) ¾ÈÁöÇý(An Ji-Hye) ±èÀºÈñ(Kim Eun-Hee) ¹Ú¼ÒÁ¤(Park So-Jung) À̼ö°æ(Lee Soo-Kyung) ±è°æ¼®(Kim Kyung-Suk)

• ´ëÇѾÏÇÑÀÇÇÐȸÁö  2012³â 17±Ç 1È£ 45~53

• ÇѹæÄ¡·á ÈÄ Gefitinib(Iresa)º¹¿ëÀ¸·Î ÀÎÇÑ ºÎÀÛ¿ë È£ÀüµÈ ºñ¼Ò¼¼Æ÷Æó¾Ï ȯÀÚ 1·Ê

• One Case Study of a Non Small Cell Lung Cancer Patient Experiencing Gefitinib Adverse Effects Managed by Traditional Korean Medicine

• ¹ÚÀç¿ì(Park Jae-Woo) ÀüÇüÁØ(Jun Hyung-Joon) Á¶Á¾°ü(Cho Chong-Kwan) ÀÌ¿¬¿ù(Lee Yeon-Weol)

• ´ëÇѾÏÇÑÀÇÇÐȸÁö  2012³â 17±Ç 1È£ 9~16

• ³ú½ÇÁú ÀüÀÌ°¡ ÀÖ´Â ºñ¼Ò¼¼Æ÷¼º Æó¾Ï ȯÀÚ¿¡¼­ÀÇ ¿¬¼ö¸· ÀüÀÌ ºóµµ ¹× ¿¹ÈÄ ÀÎÀÚ

• Incidence and Prognostic Factors of Leptomeningeal Metastasis from Non-Small Cell Lung Cancer

• ³ª¿µÃ¶(Na Young-Cheol) ±èÁöÈñ(Kim Ji-Hee) ±èÁöÈñ(Kim Ji-Hee) Àå¿ø¼®(Jang Won-Seok) ÀåÁø¿ì(Chang Jin-Woo) ¹Ú¿ë±¸(Park Yong-Gou)

• ´ëÇѳúÁ¾¾çÇÐȸÁö  2012³â 11±Ç 2È£ 102~107

• Never-Smoker Lung Cancer Is Increasing

• °­Çö¿í(Kang Hyun-Wook) ¹ÚÂù¿ì(Park Chan-Woo) ±è¿ìÁø(Kim Woo-Jin) ¼Û»óÀ±(Song Sang-Yun) ³ª±¹ÁÖ(Na Kook-Joo) Á¤Àç¿í(Jeong Jae-Uk) À±¹Ì¼±(Yoon Mee-Sun) ¾È¼ºÀÚ(Ahn Sung-Ja) ÃÖÀ¯´ö(Choi Yoo-Duk) (Choi Chan) ÀÌ´Ù¿î(Lee Da-Un) ¼±ÇöÁÖ(Seon Hyun-Ju) ±èÀ±Çö(Kim Yun-Hyeon) ±Ç¼º¿µ(Kwon Seong-Young) ¹üÈñ½Â(Bom Hee-Seung) ¿ÀÀÎÀç(Oh In-Jae) ±è±Ô½Ä(Kim Kyu-Sik) ±è¿µÃ¶(Kim Young-Chul)

• Journal of Lung Cancer  2012³â 11±Ç 2È£ 89~93

• Comparison of Therapeutic Efficacy of Gefitinib and Erlotinib in Patients with Squamous Cell Lung Cancer

• ½ÅÈ«ÁØ(Shin Hong-Joon) ±èÅ¿Á(Kim Tae-Ok) °­Çö¿í(Kang Hyun-Wook) Áö¼ö¿µ(Chi Su-Young) ¹ÝÈñÁ¤(Ban Hee-Jung) ±è¼ö¿Á(Kim Soo-Ok) ±Ç¿ë¼ö(Kwon Yong-Soo) ¿ÀÀÎÀç(Oh In-Jae) ±è±Ô½Ä(Kim Kyu-Sik) ±èÀ¯ÀÏ(Kim Yu-Il) ÀÓ¼ºÃ¶(Lim Sung-Chul) ±è¿µÃ¶(Kim Young-Chul)

• °áÇÙ¹×È£Èí±âÁúȯ  2011³â 71±Ç 1È£ 15~23

• Quantification of Serum Free RNA as a Predictive Biomarker for the Response to Chemotherapy in Patients with Lung Cancer: A Pilot Study

• ¾ö¼öÁ¤(Um Soo-Jung) À̼ö¹Ì(Lee Su-Mi) À̼ö°É(Lee Soo-Keol) ¼ÕÃáÈñ(Son Choon-Hee) °í¹Ì°æ(Ko Mee-Kyung) ³ë¹Ì¼÷(Roh Mee-Sook) À̱Ⳳ(Lee Ki-Nam) ÃÖÇÊÁ¶(Choi Pill-Jo)

• °áÇÙ¹×È£Èí±âÁúȯ  2011³â 70±Ç 4È£ 301~306

• Ç×¾ÏÄ¡·á ÁßÀÎ ºñ¼Ò¼¼Æ÷Æó¾Ï ȯÀÚÀÇ ÀÎÁöµÇÁö ¾ÊÀº ÀӽŠ1¿¹

• A case of unrecognized pregnancy during chemotherapy in non-small cell lung cancer patient

• ¹ÚÁöÀ±(Park Jee-Yoon) ¹ÚÁ¤¿ì(Park Jeong-Woo) À̵¿¿Á(Lee Dong-Ok) ¹ÚÂù¿í(Park Chan-Wook) ¹ÚÁß½Å(Park Joong-Shin) ÀüÁ¾°ü(Jun Jong-Kwan) ½ÅÈñö(Syn Hee-Chul)

• ´ëÇÑ»êºÎÀΰúÇÐȸÁö  2011³â 54±Ç 12È£ 807~811

• Bowel Perforation after Erlotinib Treatment in a Patient with Non-Small Cell Lung Cancer

• õÀ±È«(Cheon Yun-Hong) ±è¹®Áø(Kim Moon-Jin) °­¹Î±Ô(Kang Min-Gyu) ±èÈñÁø(Kim Hee-Jin) ÀÌ»ó¼ö(Lee Sang-Su) ±èÂ÷¿µ(Kim Cha-Young) Àü´ëÈ«(Jeon Dae-Hong) ±èÀ¯Àº(Kim Yu-Eun) ÀÌ°æ¿ø(Lee Gyeong-Won)

• Yonsei Medical Journal  2011³â 52±Ç 4È£ 695~698

• Æó »ù¾ÏÀ¸·Î Ç×¾ÏÄ¡·á¸¦ ¹Þ´ø ȯÀÚ¿¡¼­ ¹ß»ýÇÑ ÇǺÎÀüÀÌ »ùÆíÆò¼¼Æ÷¾Ï

• Metastatic Cutaneous Adenosquamous Carcinoma in a Patient Undergoing Chemotherapy for Lung Adenocarcinoma

• °­È£¼Û(Kang Ho-Song) ÀÌÇÏÀº(Lee Ha-Eun) Áֹμ÷(Ju Min-Sook) °íÁÖ¿¬(Ko Joo-Yeon) ³ë¿µ¼®(Ro Young-Suck)

• ´ëÇÑÇǺΰúÇÐȸÁö  2011³â 49±Ç 7È£ 606~609

• ERCC1 Predicts a Poorer Platinum-based Chemotherapy Outcome but a Better Outcome for Uracil-Tegafur in the Resected Stage I-II NSCLC

• ·ùÇѼ®(Ryu Han-Suk) (Xu Xianhua) ±èÈ¿Áø(Kim Hyo-Jin) ÀÌÁ¾¼÷(Lee Jong-Suk) Àü»óÈÆ(Jheon Sang-Hoon) Á¤ÁøÇà(Chung Jin-Haeng)

• ´ëÇѺ´¸®ÇÐȸÁö  2011³â 45±Ç 1È£ 45~52

• Gemcitabine Plus Platinum Combination Chemotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Analysis

• Àü»óÈÆ(Chun Sang-Hoon) ÀÌÁöÀº(Lee Ji-Eun) ¹Ú¹ÌÈñ(Park Mi-Hee) °­ÁøÇü(Kang Jin-Hyoung) ±è¿µ±Õ(Kim Young-Kyoon) ¿Õ¿µÇÊ(Wang Young-Pil) ¹ÚÀç±æ(Park Jae-Kil) ±èÈƱ³(Kim Hoon-Kyo)

• Cancer Research and Treatment  2011³â 43±Ç 4È£ 217~224

• Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment

• ±è´Þ¿ë(Kim Dal-Yong) ÀÌ´ëÈ£(Lee Dae-Ho) Àå¼±ÁÖ(Jang Sun-Joo) ±è»óÀ§(Kim Sang-We) (Suh Cheol-Won) ÀÌÁ¤½Å(Lee Jung-Shin)

• Cancer Research and Treatment  2011³â 43±Ç 4È£ 212~216

• Clinical Responses and Prognostic Indicators of Concurrent Chemoradiation for Non-small Cell Lung Cancer

• À̵¿¼ö(Lee Dong-Soo) ±è¿¬½Ç(Kim Yeon-Sil) °­ÁøÇü(Kang Jin-Hyoung) ÀÌ»ó³²(Lee Sang-Nam) ±è¿µ±Õ(Kim Young-Kyoun) (Ahn Myung-Im) ÇÑ´ëÈñ(Han Dae-Hee) À¯ÀÌ·É(Yoo Ie-Ryung) ¿Õ¿µÇÊ(Wang Young-Pil) (Park Jae-Gil) À±¼¼Ã¶(Yoon Sei-Chul) ÀåÈ«¼®(Jang Hong-Seok) (Choi Byung-Oak)

• Cancer Research and Treatment  2011³â 43±Ç 1È£ 32~41

• Phase II Clinical Trial of Genexol¢ç (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer

• ±èÇÑÁ¶(Kim Han-Jo) ±è°æÇÏ(Kim Kyoung-Ha) À±Áö³ª(Yun Ji-Na) ±è¼¼Çü(Kim Se-Hyung) ±èÇöÁ¤(Kim Hyun-Jung) ÀÌ»óö(Lee Sang-Cheol) ¹è»óº´(Bae Sang-Byung) ±èÂù±Ô(Kim Chan-Kyu) À̳²¼ö(Lee Nam-Su) À̱ÔÅÃ(Lee Kyu-Taek) ±èµµÁø(Kim Do-Jin) ¹Ú¼º±Ô(Park Seong-Kyu) ¿øÁ¾È£(Won Jong-Ho) È«´ë½Ä(Hong Dae-Sik) ¹ÚÈñ¼÷(Park Hee-Sook)

• Cancer Research and Treatment  2011³â 43±Ç 1È£ 19~23

• Ç×¾ÏÈ­Çпä¹ý°úÀÇ ¼øÂ÷Àû, ±×¸®°í º´ÇàÀû ¿ä¹ýÀ¸·Î¼­ÀÇ aRVS Åõ¿©·Î Àå±â »ýÁ¸°ú ÁÁÀº »îÀÇ ÁúÀ» À¯ÁöÇÑ ÀüÀ̼º ºñ¼Ò¼¼Æ÷Æó¾Ï Áõ·Êº¸°í

• Case Report : Long-term Survival and Good-Quality of Life in Metastatic Non-small Cell Lung Cancer Patients Treated with Allergen-removed Rhus verniciflua Stokes (aRVS) as Sequential and Concurrent Treatment with Chemotherapy

• ÀÌÁø¼ö(Lee Jin-Soo) ¹ÚÇüÁØ(Park Hyeong-Jun) äÁø(Chae-Jean) ±è°æ¼®(Kim Kyung-Suk) Á¤Çö½Ä(Jung Hyun-Sik) ÀÌ»óÇå(Lee Sang-Hun) ÃÖ¿øö(Choi Won-Chul) Àü¼ºÇÏ(Cheon Seong-Ha)

• ´ëÇÑÇѹ泻°úÇÐȸÁö  2011³â 32±Ç 1È£ 129~135

• Vortex Keratopathy in a Patient Receiving Vandetanib for Non-Small Cell Lung Cancer

• ¾ÈÁöÀ±(Ahn Jee-Yun) À§¿ø·®(Wee Won-Ryang) ÀÌÁøÇÐ(Lee Jin-Hak) ÇöÁØ¿µ(Hyon Joon-Young)

• Korean Journal of Ophthalmology  2011³â 25±Ç 5È£ 355~357

• ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡ »ç¿ëµÇ´Â Ç×¾ÏÈ­Çпä¹ýÀÇ ¿ä¾ç±Þ¿©±âÁØ ÀûÀý¼º Æò°¡

• Assessment of appropriateness of standard for insurance coverage on chemotherapy used in non-small cell lung cancer (NSCLC)

• ±èÁ¤¿¬(Kim Jeong-Yeon) ¹ÚÀºÁö(Park Eun-Ji) ¹è¹Î°æ(Bae Min-kyung) À±Á¤Çö(Yoon Jeong-Hyun)

• Çѱ¹ÀÓ»ó¾àÇÐȸÁö  2011³â 21±Ç 2È£ 193~207

• ºñ¼Ò¼¼Æ÷Æó¾Ï ȯÀÚÀÇ Ç¥ÇǼºÀåÀÎÀÚ ¼ö¿ëü ¾ïÁ¦Á¦ Ä¡·á¿Í °ü·ÃµÈ ÇǺÎÀÇ ÀÌ»ó¹ÝÀÀÀÌ »ç¹°ÅÁ °¡°¨¹æ Åõ¿©·Î È£ÀüµÈ 1·Ê

• A Case of Non-small Cell Lung Cancer Patient Whose Dermatologic Adverse Reactions Associated with the Epidermal Growth Factor Receptor-inhibitors were Relieved with the Treatment of a Herbal medicine, Samultang-gagambang

• ¹ÚÇüÁØ(Park Hyeong-Jun) äÁø(Chae-Jean) ÀÌÁø¼ö(Lee Jin-Soo) Á¤Çö½Ä(Jung Hyun-Sik) ÀÌ»óÇå(Lee Sang-Hun) ÃÖ¿øö(Choi Won-Chul) ±è°æ¼®(Kim Kyung-Suk)

• ´ëÇѾÏÇÑÀÇÇÐȸÁö  2011³â 16±Ç 1È£ 55~61

• ºñÆíÆò¼¼Æ÷, ºñ¼Ò¼¼Æ÷Æó¾Ï ȯÀÚ¿¡¼­ erlotinib, gefitinib ¹× pemetrexedÀÇ È¿°ú

• Clinical outcomes of erlotinib, gefitinib, or pemetrexed in patients with non-squamous, non-small-cell lung cancer

• À±¶ó¿µ(Yoon La-Young) ¾ç¹Ì¿¬(Yang Mi-Yean) À±Áø¾Æ(Yun Jin-A) ±èÇöÁ¤(Kim Hyun-Jung) ±èÇÑÁ¶(Kim Han-Jo) ±è°æÇÏ(Kim Kyoung-Ha) ±è¼¼Çü(Kim Se-Hyung) ÀÌ»óö(Lee Sang-Cheol) ±èÂù±Ô(Kim Chan-Kyu) À̳²¼ö(Lee Nam-Su) ¹Ú¼º±Ô(Park Sung-Kyu) À̱ÔÅÃ(Lee Kyu-Taek) ¿øÁ¾È£(Won Jong-Ho) ¹ÚÈñ¼÷(Park Hee-Sook) È«´ë½Ä(Hong Dae-Sik)

• ´ëÇѳ»°úÇÐȸÁö  2010³â 79±Ç 4È£ 394~403

• Bronchiolitis Obliterans Organizing Pneumonia in the Patient with Non-Small Cell Lung Cancer Treated with Docetaxel/Cisplatin Chemotherapy: A Case Report

• ±è¾Ö¶õ(Kim Ae-Ran) ±èÅ¿µ(Kim Tae-Young) ÀÌ¿µ¹Î(Lee Young-Min) À̽ÂÇå(Lee Seung-Heon) Á¤¼öÁø(Jung Soo-Jin) ÀÌÇö°æ(Lee Hyung-Kyung)

• °áÇÙ¹×È£Èí±âÁúȯ  2010³â 69±Ç 4È£ 293~297

• The Role of Monoclonal Antibody in Combination with First-Line Chemotherapy in Asian Patients with Advanced Non-Small Cell Lung Cancer

• Á¶º´Ã¶(Cho Byoung-Chul) ±èÁÖÇ×(Kim Joo-Hang) (Soo Ross-A) (Yang Chih-Hsin)

• Yonsei Medical Journal  2010³â 51±Ç 1È£ 1~8

• Risk Factors for Fatal Hemoptysis after Concurrent Chemoradiation Therapy in Patients with Non-Small Cell Lung Carcinoma

• ±èÀ±Èñ(Kim Yoon-Hee) ±èÀº¿µ(Kim Eun-Young) ¹ÝÈñÁ¤(Ban Hee-Jung) ¿ÀÀÎÀç(Oh In-Jae) ±è±Ô½Ä(Kim Kyu-Sik) ±è¿µÃ¶(Kim Young-Chul) ¾È¼ºÀÚ(Ahn Sung-Ja)

• Chonnam Medical Journal  2010³â 46±Ç 1È£ 19~24

• A Case of Metachronous Metastasis to the Breast from Non-Small Cell Lung Carcinoma

• À±¹Î¿ë(Yoon Min-Yong) ¼Ûâ¼®(Song Chang-Seok) ¼­¹ÌÇØ(Seo Mi-Hae) ±è¹ÎÀç(Kim Min-Jae) ¿ÀÅÂÀ±(Oh Tae-Yun) Àå¿îÇÏ(Jang Un-Ha) °ûÇöÁÖ(Kwag Hyon-Joo) ±èÈñ¼º(Kim Hee-Sung) Àӽÿµ(Lim Si Young) ÀÓ¼º¿ë(Lim Seong-Yong) À̼º¼¼(Lee Seung-Sae)

• Cancer Research and Treatment  2010³â 42±Ç 3È£ 172~175

• Gemcitabine º´ÇÕÄ¡·á ÈÄ ¼Ò½ÇµÈ ºñ¼Ò¼¼Æ÷Æó¾Ï º´¹ß ½ÅÁõÈıº 1¿¹

• Nephrotic Syndrome Disappeared after Gemcitabine Combination Therapy in a Patient with Progressive Non-small Cell Lung Cancer

• ÀÌÀºÁ¤(Lee Eun-Jung) ÀÌÀçÁø(Lee Jae-Jin) ¹®ÁÖ¿µ(Moon Ju-Young) À¯ÁöÈ«(Yoo Jee-Hong) ÃÖõ¿õ(Choi Cheon-Woong) ±èÀÌÇü(Kim Yee-Hyung) ±è±³¿µ(Kim Gou-Young)

• ´ëÇѽÅÀåÇÐȸÁö  2010³â 29±Ç 5È£ 634~637

• CarboplatinÀ» Æ÷ÇÔÇÑ Ç×¾ÏÁ¦ Åõ¿©È¯ÀÚ¿¡¼­ À¯¹ßµÈ ¿À½É, ±¸Åä¿¡ ´ëÇÑ palonosetron°ú ramosetronÀÇ Ç×±¸ÅäÈ¿°ú ºñ±³

• A Comparison between Palonosetron and Ramosetron in Antiemetic Effect in Patients Administered with Carboplatin-containing Anticancer Drugs

• °í¿µÁÖ(Ko Young-Joo) ÀÌ¿¬Áö(Lee Yeon-Ji) ȲÀºÁ¤(Hwang Eun-jeong) ³ªÇö¿À(La Hyen-O)

• º´¿ø¾à»çȸÁö  2010³â 27±Ç 4È£ 392~399

• Pleomorphic Carcinoma of the Lung with High Serum Beta-human Chorionic Gonadotropin Level and Gynecomastia

• (Okutur Kerem) (Hasbal Baris) (Aydin Kubra) (Bozkurt Mustafa) (Namal Esat) (Oz Buge) (Kaynak Kamil) (Demir Gokhan)

• Journal of Korean Medical Science  2010³â 25±Ç 12È£ 1805~1808

• ÁøÇ༺ ºñ¼Ò¼¼Æ÷Æó¾ÏÀÇ Ç¥ÀûÄ¡·á ¹× ¸ÂÃãÇ×¾ÏÄ¡·á

• Targeted therapy and tailored chemotherapy for advanced non-small cell lung cancer

• À±Å¹(Yun Tak)

• ´ëÇѳ»°úÇÐȸÁö  2009³â 77±Ç 1È£ 9~17

• Recurrent Erlotinib-Induced Interstitial Lung Disease on Non-Small Cell Lung Cancer

• ¹Ú»óµ·(Park Sang-Don) ±è¾Æ¸§(Kim A-Reum) ¹ÚÁø¼®(Park Jin-Seok) ½Åõȣ(Shin Chun-Ho) ³²Çؼº(Nam Hae-Sung) ±è·ç½Ã¾Æ(Kim Lucia) Á¶ÀçÈ­(Cho Jae-Hwa) ·ùÁ¤¼±(Ryu Jeong-Seon) °û½Â¹Î(Kwak Seung-Min)

• °áÇÙ¹×È£Èí±âÁúȯ  2009³â 67±Ç 5È£ 445~448

• ¿ø¹ß¼º Æó¾Ï Ä¡·á Áß ¹ß»ýÇÑ Henoch-Schonlein Purpura 1¿¹

• A Case of Henoch-Schonlein Purpura Developed during Treatment of Lung Cancer

• °­¹Î¼ö(Kang Min-Soo) ³ë±Ý¿±(Noh Geum-Yeub) À念ÁÖ(Jang Young-Joo) Á¶¼ö¿¬(Cho Soo-Youn) ÀÓ°æÁø(Lim Gyung-Jin) ³ëÈñ¼±(Noh Hee-Seon) ±èÇý·Ã(Kim Hye-Ryoun) ±èöÇö(Kim Cheol-Hyeon) ÀÌÀçö(Lee Jae-Cheol)

• °áÇÙ¹×È£Èí±âÁúȯ  2009³â 67±Ç 3È£ 234~238

• ÁøÇ༺ ºñ¼Ò¼¼Æ÷Æó¾Ï ȯÀÚ¿¡¼­ PemetrexedÀÇ È¿°ú¿Í ¾ÈÀü¼º

• Efficacy and Safety of Pemetrexed in Advanced Non-Small Cell Lung Carcinoma

• À̱ÔÁø(Lee Gyu-Jin) Á¤¸¸È«(Jung Maan-Hong) ÀåÅ¿ø(Jang Tae-Won) ¿Áöȣ(Oak Chul-Ho) Á¤ÇöÁÖ(Jung Hyun-Joo)

• °áÇÙ¹×È£Èí±âÁúȯ  2009³â 67±Ç 2È£ 121~126

• ºñ¼Ò¼¼Æ÷ Æó¾ÏȯÀÚ¿¡¼­ Docetaxel Åõ¿© Áß ¹ß»ýÇÑ ¾Æ±Þ¼º ÇǺΠȫ¹Ý·çǪ½º 1¿¹

• A Case of Docetaxel Induced Subacute Cutaneous Lupus Erythematosus

• ½ÅÁ¤¾Æ(Shin Jung-Ar) Çãö¿õ(Huh Cheal-Wung) ±ÇÁöÀº(Kwon Ji-Eun) ±èÇüÁß(Kim Hyung-Jung) ¾Èö¹Î(Ahn Chul-Min) ÀåÀ±¼ö(Chang Yoon-Soo)

• °áÇÙ¹×È£Èí±âÁúȯ  2009³â 66±Ç 5È£ 380~384

• Ç×¾ÏÈ­ÇÐÄ¡·á ÈÄ ¹ß»ýÇÑ Ç×ÀÌ´¢È£¸£¸ó ºÎÀûÀý ºÐºñ ÁõÈıº 1¿¹

• A Case of Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Chemotherapy in a Patient with Non-Small-Cell Lung Cancer

• ÀÌ°æÁÖ(Lee Kyung-Joo) À̼º¿ë(Lee Sung-Yong) ÀÌ»ó¿±(Lee Sang-Yeub) ±èÁ¦Çü(Kim Je-Hyeong) ½Åö(Shin Chol) ½ÉÀçÁ¤(Shim Jae-Jeong) Àα¤È£(In Kwang-Ho) °­°æÈ£(Kang Kyung-Ho) À¯¼¼È­(Yoo Se-Hwa) ¹®À翵(Moon Jae-Young)

• °áÇÙ¹×È£Èí±âÁúȯ  2009³â 66±Ç 4È£ 324~328

• ºñ¼Ò¼¼Æ÷Æó¾Ï ȯÀÚÀÇ ¾çÀüÀÚ¹æÃâ ´ÜÃþÃÔ¿µ¿¡¼­ °ñ¼ö ´ë»çÈ°¼ºµµÀÇ Ç×¾ÏÈ­Çпä

• Association between Bone Marrow Hypermetabolism on 18F-Fluorodeoxyglucose

• ¼³ÈñÀ±(Seol Hee-Yun) ±è¼ºÀå(Kim Seong-Jang) ¸ñÁ¤ÇÏ(Mok Jeong-Ha) ±èÁöÀº(Kim Ji-Eun) ±è±â¿í(Kim Ki-Uk) ¹ÚÇý°æ(Park Hye-Kyung) ±èÀ±¼º(Kim Yun-Seong) À̹αâ(Lee Min-Ki) ¹Ú¼ø±Ô(Park Soon-Kew) À±¼ºÈÆ(Yoon Seong-Hoon)

• °áÇÙ¹×È£Èí±âÁúȯ  2009³â 66±Ç 1È£ 20~26

• Paclitaxel°ú Carboplatin Ç×¾Ï È­ÇÐ ¿ä¹ý ÈÄ¿¡ ¹ß»ýÇÑ À§¸· ´ëÀå¿° 1¿¹

• A Case of Pseudomenbranous Colitis after Paclitaxel and Carboplatin Chemotherapy

• ¾ç¼º¿ì(Yang Seung-Wu) ¹®¿ø(Moon Won)

• ´ëÇѼÒÈ­±âÇÐȸÁö  2009³â 54±Ç 5È£ 328~332

• ÁøÇ༺ ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡¼­ KRAS¿Í TauÀÇ Ç×¾Ï Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀÀÇ ¿¹Ãø ÀÎÀڷμ­ÀÇ ÀÇÀÇ

• Predictive Significance of KRAS and Tau for Chemoresponse in Advanced Non-Small-Cell Lung Cancer

• À¯Áø¿µ(Yoo Jin-Young) °­¼®Áø(Kang Seok-Jin) À¯Ã¢¿µ(Yoo Chang-Young) ½Éº´¿ë(Shim Byoung-Yong) À̱³¿µ(Lee Kyo-Young)

• ´ëÇѺ´¸®ÇÐȸÁö  2009³â 43±Ç 5È£ 435~440

• º´¸®ÇÐÀû º´±â Ia±â ºñ¼Ò¼¼Æ÷Æó¾Ï ȯÀÚ¿¡¼­ ¿ÏÀüÀýÁ¦¼ú ÈÄ »ç¸ÁÀÇ ¿øÀο¡ µû¸¥ À§ÇèÀÎÀÚ ºÐ¼®

• Cause-specific Analysis of Risk Factors in Completely Resected Pathologic Stage Ia Non-small Cell Lung Cancer

• ¹Ú¼º¿ë(Park Seong-Yong) ¹ÚÀαÔ(Park In-kyu) º¯Ãµ¼º(Byeon Cheun-Sung) ÀÌ⿵(Lee Chang-Young) ¹è¹Ì°æ(Bae Mi-Kyung) ±è´ëÁØ(Kim Dae-Joon) Á¤°æ¿µ(Chung Kyung-Young)

• ´ëÇÑÈäºÎ¿Ü°úÇÐȸÁö  2009³â 42±Ç 6È£ 725~731

• ¿ÏÀü ÀýÁ¦µÈ IB ºñ¼Ò¼¼Æ÷¾Ï¿¡¼­ Àç¹ßÀÇ ¿¹ÈÄÀÎÀÚ·ÎÀÇ ÀåÃø´Á¸· ħ¹ü

• Visceral Pleural Invasion as a Prognostic Factor for Recurrence in Resected IB Non-small Cell Lung Cancer

• ±è¼®(Kim Seok) ¹Ú±â¼º(Park Ki-Sung) ±ÝÀ±¼·(Kum Yoon-Seup) À̼·(Lee Sub) ¹èÁöÈÆ(Bae Chi-Hoon) Çö´ë¼º(Hyun Dae-Sung)

• ´ëÇÑÈäºÎ¿Ü°úÇÐȸÁö  2009³â 42±Ç 5È£ 610~614

• The Concurrent Use of Rhus verniciflua Stokes as Complementary Therapy with Second or More Line Regimens on Advanced Non-small-cell Lung Cancer: Case Series

• ÀÌ»óÇå(Lee Sang-Hun) ±è°æ¼®(Kim Kyung-Suk) ÃÖ¿øö(Choi Won-Chul) À±¼º¿ì(Yoon Seong-Woo)

• ´ëÇÑÇÑÀÇÇÐȸÁö  2009³â 30±Ç 6È£ 112~117

• ÇÁ·Î½ºÅ¸±Û¶õµò ºÐÇØÈ¿¼Ò 15-Hydroxyprostaglandin DehydrogenaseÀÇ Á¾¾ç¾ïÁ¦ ±â´É ¹× ±× ¹ßÇöÁ¶Àý ±âÀü

• Role of 15-Hydroxyprostaglandin Dehydrogenase as a Tumor Suppressor and Its Underlying Molecular Mechanism

• ÃÖÁöÀº ÀÌÈñ±Ý ¼­¿µÁØ(Surh Young-Joon) ¸í½ÂÀç(Myung Seung-Jae) ³ªÇý°æ(Na Hye-Kyung)

• Cancer Prevention Research  2009³â 14±Ç 3È£ 201~207

• ¹ÝÇϹéÃâõ¸¶ÅÁ °¡°¨¹æÀ» Åõ¿©ÇÏ¿© ºñ¼Ò¼¼Æ÷¼º Æó¾ÏÀÇ ³úÀüÀÌ¿¡ ÀÇÇÑ µÎÅëÀÌ È£ÀüµÈ 1·Ê

• A Case Report of Non-small Cell Lung Cancer with Brain Metastasis Patient Treated with Banhabaekchulchoenma-tang Gagambang

• À̼±Çà(Lee Sun-Hang) ÀÌÁø¼ö(Lee Jin-Soo) (Jung Hyun) ÃÖ¿øö(Choi Won-Cheol) ±è°æ¼®(Kim Kyung-Suk)

• ´ëÇѾÏÇÑÀÇÇÐȸÁö  2009³â 14±Ç 1È£ 45~52

• ¾Ë·¯Á¨ Á¦°Å ¿Ì³ª¹« ÃßÃâ¹° À§ÁÖÀÇ ÇѹæÄ¡·á¿Í Ç×¾ÏÈ­Çпä¹ýÀ» º´¿ëÇÑ Æó¾Ï ȯÀÚ 2·Ê

• Two Cases of Non-small Cell Lung Cancer Patients Treated with Allergen Removed Rhus Verniciflua Stokes Based Traditional Korean Medicine and Chemotherapy

• ±ÇÀº¹Ì(Kwon Eun-Mi) Á¤ÀǹÎ(Jeorng Ui-Min) ±è°æ¼®(Kim Kyung-Suk) À̼ö°æ(Lee Soo-Kyung) ÃÖ¿øö(Choi Won-Cheol) À±¼º¿ì(Yoon Sung-Woo)

• ´ëÇѾÏÇÑÀÇÇÐȸÁö  2009³â 14±Ç 1È£ 13~20

• ºñ¼Ò¼¼Æ÷Æó¾ÏÀÇ µ¿Ãø À¯¹æÀüÀÌ: Áõ·Êº¸°í

• Metastasis of Non-Small Cell Lung Cancer to Ipsilateral Breast: A Case Report

• ±èÁØÈ£(Kim Jun-Ho) ¿°Â÷°æ(Yom Cha-Kyong) ±è¿µÀº(Kim Yeoung-Eun) ¹Ú¿ë·¡(Park Yong-Lai) ¹è¿ø±æ(Bae Won-Gil) ¿ÀÅÂÀ±(Oh Tae-Yun) ¼ÕÁøÈñ(Sohn Jin-Hee)

• Journal of Breast Cancer  2009³â 12±Ç 3È£ 215~218

• Combining Erlotinib with Cytotoxic Chemotherapy May Overcome Resistance Caused by T790M Mutation of EGFR Gene in Non-Small Cell Lung Carcinoma

• ¿ÀÀÎÀç(Oh In-Jae) ±è±Ô½Ä(Kim Kyu-Sik) Á¤ÁÖ¿¬(Jeong Ju-Yeon) Á¶ÇöÁÖ(Cho Hyun-Ju) ±è¿µÃ¶(Kim Young-Chul)

• Journal of Lung Cancer  2009³â 8±Ç 2È£ 92~98

• Investigating Effective Combinations of Anti-cancer Drugs and Radiation Therapy for Treating Non-small Cell Lung Cancer with Using Two Cell Lines

• ¿ÀÀÎÀç(Oh In-Jae) Á¶ÇöÁÖ(Cho Hyun-Ju) (Tseden-Ish Manaljav) ±Ç¿ë¼ö(Kwon Yong-Soo) ±è±Ô½Ä(Kim Kyu-Sik) ÀÓ¼ºÃ¶(Lim Sung-Chul) ±è¿µÃ¶(Kim Young-Chul) ¾È¼ºÀÚ(Ahn Sung-Ja)

• Journal of Lung Cancer  2009³â 8±Ç 1È£ 21~30

• The Prognostic and Predictive Value of EGFR and HER-2 in Advanced Non-small Cell Lung Cancer Patients Who Are Treated with Cisplatin and Paclitaxel

• À¯Áø¿µ(Yoo Jin-Young) ½Éº´¿ë(Shim Byoung-Yong) °­¼®Áø(Kang Seok-Jin)

• Journal of Lung Cancer  2009³â 8±Ç 1È£ 13~20

• Concurrent Chemoradiotherapy with Weekly Paclitaxel for Locally Advanced Non-small Cell Lung Cancer

• Á¤¼ºÇö(Jeong Seong-Hyun) Á¤ÀçÈ£(Jung Jae-Ho) ÀÌÇö¿ì(Lee Hyun-Woo) °­¼®À±(Kang Seok-Yun) ¾È¹Ì¼±(Ahn Mi-Sun) ÃÖ¿ë¿ø(Choi Yong-Won) ȲÀ±È£(Hwang Yoon-Ho) ¿À¿µÅÃ(Oh Young-Taek) ÃÖÁøÇõ(Choi Jin-Hyuk) ½Å½Â¼ö(Shin Seung-Soo) ¹Ú±¤ÁÖ(Park Kwang-Joo)

• Journal of Lung Cancer  2009³â 8±Ç 1È£ 8~12

• Management of Locally Advanced Non-small Cell Lung Cancer

• (Paul DeRose) (Choy Hak) Á¶ÀçÈ£(Cho Jae-ho)

• Journal of Lung Cancer  2009³â 8±Ç 1È£ 1~7

• ³ëÀο¡¼­ÀÇ Æó¾ÏÄ¡·á

• Treatment of lung cancer in the elderly

• ÀÌÁ¤Àº(Lee Jeong-Eun) ±è¼±¿µ(Kim Sun-Young)

• ´ëÇѳ»°úÇÐȸÁö  2008³â 75±Ç 2È£ 162~168

• ´ë±¸ °æºÏÁö¿ª¿¡¼­ Áø´ÜµÈ ³ë·ÉÀÚ Æó¾ÏÀÇ ÀÓ»óÀû Ư¡°ú ¿¹ÈÄ

• The Clinical Characteristics and Prognosis of Elderly Patients with Lung Cancer Diagnosed in Daegu and Gyeongsangbukdo

• ±èÇö¼÷(Kim Hyun-Sook) Àü¿µÁØ(Jeon Young-June) Çѽ¹ü(Han Seung-Beom) ±è°æÂù(Kim Kyung-Chan) ½Å°æö(Shin Kyeong-Cheol) Á¤ÁøÈ«(Chung Jin-Hong) ÀÌ°üÈ£(Lee Kwan-Ho) Çö´ë¼º(Hyun Dae-Sung) ÀÌ»óä(Lee Sang-Chae) Á¤Ä¡¿µ(Jung Chi-Young) ±è¿¬Àç(Kim Yeon-Jae) Â÷½ÂÀÍ(Cha Seung-Ick) ±èâȣ(Kim Chang-Ho) ¹ÚÀç¿ë(Park Jae-Yong) Á¤ÅÂÈÆ(Jung Tae-Hoon) ÃÖ¿øÀÏ(Choi Won-Il) ÀÓ°ÇÀÏ(Lim Gune-Il)

• °áÇÙ¹×È£Èí±âÁúȯ  2008³â 65±Ç 1È£ 15~22

• Æó¾ÏÀÇ Ç¥ÀûÄ¡·áÁ¦

• Targeted Therapy of Lung Cancer

• À̰迵(Lee Kye-Young)

• ´ëÇÑÀÇ»çÇùȸÁö  2008³â 51±Ç 5È£ 483~491

• PlatinumÁ¦·Î Ç×¾Ï Ä¡·áÇÑ ÁøÇ༺ ºñ¼Ò¼¼Æ÷Æó¾ÏÁ¾ ȯÀÚ¿¡¼­ HER-2/neu, ERCC1°ú GST-pi¿¡ ´ëÇÑ ¿¬±¸

• An Analysis of HER-2/neu, ERCC1, and GST-pi in Advanced Non-Small Cell Lung Cancer Patients Who are Treated with Platinum-based Chemotherapy

• ¼­°æÁø(Seo Kyung-Jin) ½Éº´¿ë(Shim Byoung-Yong) ±èÈƱ³(Kim Hoon-Kyo) Á¤ÁöÇÑ(Jung Ji-Han) À¯Áø¿µ(Yoo Jin-Young) °­¼®Áø(Kang Seok-Jin) À̱³¿µ(Lee Kyo-Young)

• ´ëÇѺ´¸®ÇÐȸÁö  2008³â 42±Ç 6È£ 327~334

• ºñ¼Ò¼¼Æ÷Æó¾ÏÁ¾¿¡¼­ EGFR ´Ü¹é ¹ßÇö°ú À¯ÀüÀÚ ÁõÆøÀÌ Á¦ÇÇƼ´Õ Ä¡·á¿¡ ¹ÌÄ¡´Â ¿µÇâ

• Protein Expression and Gene Amplification of Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer: Correlation with the Response to Gefitinib Therapy

• À¯Áø¿µ(Yoo Jin-Young) ½Éº´¿ë(Shim Byoung-Yong) Á¶±Ôµµ(Cho Kyu-Do) ±è¼ºÈ¯(Kim Sung-Hwan) ±èÄ¡È«(Kim Chi-Hong) ±èÈƱ³(Kim Hoon-Kyo) ÀÌ°æÁö(Lee Kyung-Ji) ¾È¸íÀÓ(Ahn Myeong-Im) Á¶´ö°ï(Cho Deog-Gon) Á¤ÁöÇÑ(Jung Ji-Han) °­¼®Áø(Kang Seok-Jin)

• ´ëÇѺ´¸®ÇÐȸÁö  2008³â 42±Ç 1È£ 1~8

• IIIA±â ºñ¼Ò¼¼Æ÷ Æó¾ÏȯÀÚ¿¡¼­ ½Åº¸Á¶ Ç׾Ϲæ»ç¼±Ä¡·á ÈÄ Nº´±âÀÇ º¯È­¿¡ µû¸¥ »ýÁ¸À² ºñ±³

• Survival of Stage IIIA NSCLC Patients with Changes in N Stage after Neoadjuvant Chemoradiotherapy

• ¹èÁöÈÆ(Bae Chi-Hoon) ¹Ú½ÂÀÏ(Park Seung-Il) ±è¿ëÈñ(Kim Yong-Hee) ±èµ¿°ü(Kim Dong-Kwan)

• ´ëÇÑÈäºÎ¿Ü°úÇÐȸÁö  2008³â 41±Ç 5È£ 586~590

• Gemcitabine and Carboplatin Combination Chemotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer: A Feasibility Study

• À¯¿µÁø(Yuh Young-Jin) ÀÌÈ¿¶ô(Lee Hyo-Rac) ±è¼º·Ï(Kim Sung-Rok)

• Cancer Research and Treatment  2008³â 40±Ç 3È£ 116~120

• ºñ¿ë-È¿°ú ºÐ¼® ±â¹ýÀ» ÀÌ¿ëÇÑ Gemcitabine ¿Ü·¡ Ç×¾Ï Ä¡·áÀÇ °æÁ¦¼º Æò°¡

• Economic evaluation of Gemcitabine-cisplatin Chemotherapy for Non Small-Cell Lung Cancer Patient in an Outpatient Setting

• ¹Î¼öÇö(Min Su-Hyun) °í¼ö°æ(Ko Su-Kyoung) ÀÓÁö¿µ(Lim Ji-Young)

• Journal of Korean Academy of Nursing  2008³â 38±Ç 3È£ 363~371

• ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡¼­ µ¿½ÃÈ­Çйæ»ç¼±¿ä¹ýÀ» ¹Þ´Â Áß »ý±ä ±â°üÆó·ç1·Ê

• A Case of Bronchopulmonary Fistula Occurring while chemoradiotherapy for Advanced Non small Cell Lung Cancer

• °­°ÇÈñ(Kang Gun-Hi) Á¶¼º¿ì(Cho Sung-Woo) ±è¼º·Ï(Kim Sung-Rok) À¯¿µÁø(Yuh Young-Jin) ÀÌÈ¿¶ô(Lee Hyo-Rac)

• ÀÎÁ¦ÀÇÇР 2008³â 29±Ç 1È£ 59~67

• ºñ¼Ò¼¼Æ÷Æó¾Ï ȯÀÚ¿¡ À־ Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsÀÇ ¾àÈ¿ ¹× rash ¹ß»ý°ú °ü·ÃÇÑ ÀÎÀÚ¿¡ ´ëÇÑ ¿¬±¸

• Factors associated with effectiveness of and rash occurrence by Epider-mal Growth Factor Receptor Tyrosine Kinase Inhibitors in patients with non-small cell lung cancer

• ¹è³ª·¡(Bae Na-Rae) ÃÖÇýÁø(Choi Hye-Jin) À̺´±¸(Lee Byung-Koo) °ûÇý¼±(Gwak Hye-Sun)

• ¾àÇבּ¸³í¹®Áý-ÀÌÈ­¿©ÀÚ´ëÇб³  2008³â 19±Ç 1È£ 86~94

• ºñ¼Ò¼¼Æ÷Æó¾Ï ȯÀÚ¿¡ À־ Epidermal Growth Factor Receptor TyrosineKinase InhibitorsÀÇ ¾àÈ¿ ¹× rash ¹ß»ý°ú °ü·ÃÇÑ ÀÎÀÚ¿¡ ´ëÇÑ ¿¬±¸

• Factors associated with effectiveness of and rash occurrence by Epider-mal Growth Factor Receptor Tyrosine Kinase Inhibitors in patients with non-small cell lung cancer

• ¹è³ª·¡(Bae Na-Rae) ÃÖÇýÁø(Choi Hye-Jin) À̺´±¸(Lee Byung-Koo) °ûÇý¼±(Gwak Hye-Sun)

• Çѱ¹ÀÓ»ó¾àÇÐȸÁö  2008³â 18±Ç 2È£ 75~83

• A Case of Pneumatosis Intestinalis Induced by Chemotherapy in a Patient with Lung Cancer

• ±Ç¹ÌÇý(Kwon Mi-Hye) ±Ç¼±Áß(Kwon Sun-Jung) ÃÖÀ¯Áø(Choi Eu-Gene) ³ª¹®ÁØ(Na Moon-Jun) ¼ÕÁö¿õ(Son Ji-Woong)

• Journal of Lung Cancer  2008³â 7±Ç 2È£ 101~102

• Clinical Features of the Lung Cancer Patients Who Were Seen in Kosin University Gospel Hospital from 1994 to 1998

• ÀåÅ¿ø(Jang Tae-Won) Á¤¸¸È«(Jung Maan-Hong)

• Journal of Lung Cancer  2008³â 7±Ç 2È£ 81~85

• Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients

• °íÀ±È£(Ko Yoon-Ho) À̸í¾Æ(Lee Myung-Ah) È«¿µ¼±(Hong Yeong-Seon) ÀÌ°æ½Ä(Lee Kyung-Shik) ¹ÚÇöÁø(Park Hyun-Jin) À¯ÀÌ·É(Yoo Ie-Ryung) ±è¿¬½Ç(Kim Yeon-Sil) ±è¿µ±Õ(Kim Young-Kyoon) Á¶°ÇÇö(Jo Keon-Hyun) ¿Õ¿µÇÊ(Wang Young-Pil) À̱³¿µ(Lee Kyo-Young) °­ÁøÇü(Kang Jin-Hyoung)

• The Korean Journal of Internal Medicine  2007³â 22±Ç 3È£ 178~185

• Compliance with Adjuvant Chemotherapy for Completely Resected Non-small Cell Lung Cancer

• ÀÌÇö¼º(Lee Hyun-Sung) ±è¹®¼ö(Kim Moon-Soo) ÀÌÁ¾¸ñ(Lee Jong-Mog) ±èÈïÅÂ(Kim Heung-Tae) Ȳº¸·æ(Hwang Bo-Ryong) Çѵ¿¼®(Han Dong-Seok) ¾ÈÇö°æ(Ahn Hyun-Kyong) Á¶ÀçÀÏ(Zo Jae-Ill)

• Journal of Lung Cancer  2007³â 6±Ç 2È£ 78~84

• °í·ÉÀÇ ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡¼­ Paclitaxel ´Üµ¶¿ä¹ý

• Paclitaxel for elderly patients with advanced NSCLC

• ¿ìâ¹Î/Woo CM ±è¼Ò¿¬/À̼±¾Æ/¿ÀÈ¿Áø/¹è¼ºÈ­/·ùÇå¸ð/±è°æÂù/Çö´ë¼º/ÀÌ»óä/µµ¿µ·Ï/¼ÛÈ«¼®/Kim SY/Lee SA/Oh HJ/Bae SH/Ryoo HM/Kim KC/Hyun DS/Lee SC/Do YR/Song HS

• ´ëÇѳ»°úÇÐȸÁö  2006³â 70±Ç 2È£ 183~189

• º¸Á¶Ç×¾ÏÈ­ÇÐÄ¡·á ÈÄ ¹ß»ýÇÑ Ç×ÀÌ´¢È£¸£¸óºÐºñÀÌ»óÁõÈıº

• Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Adjuvant Chemotherapy with Cisplatin plus Paclitaxel in Non-Small Cell Lung Cancer Patient

• ¹é¿ë¼ö(Baek Yong-Soo) ·ùÁ¤¼±(Ryu Jeong-Seon) È«¼ººó(Hong Seong-Bin) À¯¼º¼ö(Yoo Sung-Soo) À¯Çü±Ç(Yu Hyung-Kwon) ¼Õµ¿¿í(Son Dong-Wook) ±è·ç½Ã¾Æ(Kim Lucia) °­Çý¼±(Kang Hye-Sun) ±è¹üÁØ(Kim Beom-Joon) ÀÌ°æÈñ(Lee Kyung-Hee) Á¶ÀçÈ­(Cho Jae-Hwa) À±¿ëÇÑ(Yoon Young-Han) °û½Â¹Î(Kwak Seung-Min) ÀÌÈ«·Ä(Lee Hong-Lyeol) ±è±¤È£(Kim Kwang-Ho)

• °áÇÙ¹×È£Èí±âÁúȯ  2006³â 61±Ç 6È£ 591~594

• ÁøÇ༺ ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡¼­ Heme oxygenase-1 ¹ßÇö°ú CisplatinÀ» Æ÷ÇÔÇÏ´Â Ç×¾ÏÈ­Çпä¹ýÀÇ Ä¡·á¹ÝÀÀ°úÀÇ ¿¬°ü¼º

• The Relationship between Heme Oxygenase-1 Expression and Response to Cisplatin Containing Chemotherapy in Advanced Non-Small Cell Lung Cancer

• ¾çµÎ°æ/Yang DK ³ë¹Ì¼÷/ÀÌ°æÀº/±è±â³²/À̱Ⳳ/ÃÖÇÊÁ¶/¹æÁ¤Èñ/±èº¸°æ/¼­È¿¸²/±è¹ÎÁö/±è½½±â/À̼ö°É/¼ÕÃáÈñ/Roh MS/Lee KE/Kim KN/Lee KN/Choi PJ/Bang JH/Kim BK/Seo HR/Kim MJ/Kim SK/Lee SK/Son CH

• °áÇÙ¹×È£Èí±âÁúȯ  2006³â 60±Ç 3È£ 314~320

• The Efficacy and Safety of Padexol (Paclitaxel) and Cisplatin for Treating Advanced Non-small Cell Lung Cancer

• Kim HK Kim JS/Ryoo HM/Shin DG/Shim BY/Park KH/Bae SH/Kim CH

• Cancer Research and Treatment  2006³â 38±Ç 2È£ 66~71

• IIIB º´±â ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡¼­ Paclitaxel°ú CisplatinÀ» ÀÌ¿ëÇÑ ¼±ÇàÇ×¾ÏÈ­Çпä¹ý°ú µ¿½Ã Ç×¾ÏÈ­Çйæ»ç¼±Ä¡·á

• Paclitaxel and Cisplatin with Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Stage IIIB Non-small Cell Lung Cancer

• °­±â¹®(Kang Ki-Mun) ÀÌ°æ¿ø(Lee Gyeong-Won) ±èÈƱ¸(Kim Hoon-Gu) ÀÌ¿ø¼·(Lee Won-Seop) ä±Ô¿µ(Chai Gyu-Young)

• ´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö  2006³â 24±Ç 4È£ 223~229

• Preoperative Concurrent Radiochemotherapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer

• Kang MK Ahn YC/Lim DH/Park KC/Shim YM/Kim JG/Kim KM

• Journal of Korean Medical Science  2006³â 21±Ç 2È£ 229~235

• Æó¾Ï°ú º´¹ßÇÑ ·ù¸¶Æ¼½º °üÀý¿° ȯÀÚ¿¡¼­ Ç׾Ͽä¹ý¿¡ µû¸¥ ÀÓ»ó°æ°ú

• ÃÖ¼±¿í/Choi SO Á¤Àç±Ô/Çüº¹Áø/¹Ú»ó¹Ì/Á¤ÇöÁ¤/¹Úº¸Çü/½Éº´¿ë/±è¿Ï¿í/±èÈƱ³/Jung JG/Hyoung BJ/Park SM/Jung HJ/Park BH/Shim BY/Kim WU/Kim HK

• ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö  2006³â 13±Ç 2È£ 166~170

• ºñ¼Ò¼¼Æ÷¾ÏÀÇ ³úÀüÀÌ¿¡ ´ëÇÑ °³µÎ¼ú ¹× Á¾¾çÀýÁ¦¼ú ÈÄ º¸Á¶Àû Ä¡·áÀÇ °á°ú

• Result of Adjuvant Therapy after Metastatectomy for Brain Metastasis from Non-small Cell Lung Cancer

• ±è¿µÁØ(Kim Young-Zoon) À¯Çå(Yoo Heon) ¾çÈñ¼®(Yang Hee-Seok) ½Å»óÈÆ(Shin Sang-Hoon) À̼ºÈÆ(Lee Seung-Hoon)

• ´ëÇѳúÁ¾¾çÇÐȸÁö  2006³â 5±Ç 2È£ 77~84

• ±¹¼ÒÁøÇ༺ ºñ¼Ò¼¼Æ÷Æó¾Ï ȯÀÚ¿¡¼­ weekly paclitaxelÀ» ÀÌ¿ëÇÑ È­ÇÐ ¹æ»ç¼± µ¿½Ã¿ä¹ýÀÇ È¿°ú

• Efficacy of weekly paclitaxel and concurrent radiation therapy for Locally advanced non-small cell Lung cancer

• ¹è¼ºÈ­/Bae SH ±è°æÂù/À̼±¾Æ/±è¼Ò¿¬/·ùÇå¸ð/Çö´ë¼º/ÀÌ»óä/¿¹Áö¿ø/¹èÁ¾¿±/Á¤°æÀç/À±»ó¸ð/±è¹Î°æ/Kim KC/Lee SA/Kim SY/Ryoo HM/Hyun DS/Lee SC/Yei JW/Bae JY/Jung KJ/Yun SM

• ´ëÇѳ»°úÇÐȸÁö  2005³â 69±Ç 4È£ 379~386

• ÁøÇ༺ ºñ¼Ò¼¼Æ÷Æó¾ÏÀÇ ÀÌÂ÷Ç×¾ÏÈ­Çпä¹ýÀ¸·Î¼­ Docetaxel ´Üµ¶¿ä¹ýÀÇ ¼ºÀû

• Docetaxel as Second-line Monotherapy for Advanced Non-small Cell Lung Cancer

• °­Çö¸ð/Kang HM ÀÌÁ¤Àº/ÀåÇʼø/ÀÌ¿¬¼±/±Ç¼±Áß/¾ÈÁø¿µ/Á¤¼º¼ö/±èÁÖ¿Á/±è¼±¿µ/Lee JE/Jang PS/Lee YS/Kwon SJ/An JY/Jung SS/Kim JO/Kim SY

• °áÇÙ¹×È£Èí±âÁúȯ  2005³â 58±Ç 5È£ 465~472

• ºñ¼Ò¼¼Æ÷ Æó¾Ï ȯÀÚÀÇ ÀÌÂ÷ Ä¡·á·Î¼­ °ú È¥ÇÕ Gemcitabine Vinorelbine¿ä¹ýÀÇ È¿°ú

• Gemcitabine Plus Vinorelbine as Second-line Chemotherapy of the Patients of Previously Treated Non-small Cell lung Cancer: Phase II Trial

• ÀåÇʼø/Jang PS °­Çö¸ð/ÀÌÁ¤Àº/±Ç¼±Áß/¾ÈÁø¿µ/ÀÌ¿¬¼±/Á¤¼º¼ö/±èÁÖ¿Á/±è¼±¿µ/Kang HM/Lee JE/Kwon SJ/An JY/Lee YS/Jeong SS/Kim JO/Kim SY

• °áÇÙ¹×È£Èí±âÁúȯ  2005³â 58±Ç 4È£ 344~351

• ¼Ò¼¼Æ÷Æó¾Ï¿¡¼­ Multidrug Resistance-1 À¯ÀüÀÚÀÇ ´ÙÇü¼º°ú Etoposide-cisplatin Ç×¾ÏÈ­Çпä¹ý ¹ÝÀÀÀÇ °ü°è

• The Relationship between MDR1 Polymorphisms and the Response to Etoposide/Cisplatin Combination Chemotherapyin Small Cell Lung Cancer

• ¼ÕÁö¿õ/Sohn JW À̽ſ±/À̼öÁ¤/ÀüÈ¿¼º/ÀÌÀçÈñ/¹ÚÀçÇü/±èÀºÁø/Â÷½ÂÀÍ/±èâȣ/°­¿µ¸ð/Á¤ÅÂÈÆ/¹ÚÀç¿ë/Lee SY/Lee SJ/Jeon HS/Lee JH/Park JH/Kim EJ/Cha SI/Kim CH/Kang YM/Lee JT/Jing TH/Park JY

• °áÇÙ¹×È£Èí±âÁúȯ  2005³â 58±Ç 2È£ 135~141

• The Safety and Efficacy of Second-line Single Docetaxel (75 mg/m2) Therapy in Advanced Non-Small Cell Lung Cancer Patients who were Previously Treated with Platinum-based Chemotherapy

• Shim BY Kim CH/Song SH/Ahn MI/Hong EJ/Kim SW/Kim SZ/Jo MS/Cho DG/Cho KD/Yoo JY/Kim HK

• Cancer Research and Treatment  2005³â 37±Ç 6È£ 339~343

• Results of Curative Radiation Therapy with or without Chemotherapy for Stage III Unresectable Non-Small Cell Lung Cancer

• Ahn SJ Kim YC/Kim KS/Park KO/Chung WK/Nam TK/Nah BS/Song JY/Yoon MS

• Cancer Research and Treatment  2005³â 37±Ç 5È£ 268~272

• Multimodality Treatment Based on Induction Chemotherapy for Stage III NSCLC

• ÀÌ¿¬¼±(Lee Yeun-Seun) ÀåÇʼø(Jang Pill-Soon) °­Çö¸ð(Kang Hyun-Mo) (Lee Jeung-Eyeun) Á¶ÁÖ¹®(Jo Ju-Moon) (Lim Pyeung-Seung) Á¤¼º¼ö(Jung Sung-Soo) ±èÁÖ¿Á(Kim Ju-Ock) ±è¼±¿µ(Kim Sun-Young)

• Journal of Lung Cancer  2005³â 4±Ç 2È£ 81~88

• Phase II Trial of Docetaxel and Ifosfamide for Patients with Platinum-Resistant or Refractory Non-Small Cell Lung Cancer in a Salvage Setting

• Lee GW Kang JH/Kim SH/Lee HY/Kim HC/Lee WS/Lee JD/Hwang YS/Jang JS/Lee JS

• Cancer Research and Treatment  2004³â 36±Ç 5È£ 287~292

• Intrapleural Chemotherapy with Cisplatin and Cytarabine in the Management of Malignant Pleural Effusion

• Kim KW Park SY/Kim MS/Kim SC/Lee EH/Shin SY/Lee JH/Kweon JB/Park K

• Cancer Research and Treatment  2004³â 36±Ç 1È£ 68~71

• The Addition of Induction Chemotherapy Failed to Improve Therapeutic Outcome of Concurrent Chemoradiotherapy in Patients with Locally Advanced Non-small Cell Lung Cancer

• ÀÌÇö¿ì(Lee Hyun-Woo) ÃÖ½ÂÁØ(Choi Seung-Jun) ÃÖÁøÇõ(Choi Jin-Hyuk) ÀÓÈ£¿µ(Lim Ho-Yeong) ±èȿö(Kim Hugh-Chul) °­½ÂÈñ(Kang Seung-Hee) ¿À¿µÅÃ(Oh Young-Taek) Àü¹Ì¼±(Chun Mi-Son) ½Å½Â¼ö(Shin Seung-Soo) ¿ÀÀ±Á¤(Oh Yoon-Jung) ¹Ú±¤ÁÖ(Park Kwang-Joo) Ȳ¼ºÃ¶(Hwang Sung-Chul)

• Journal of Lung Cancer  2004³â 3±Ç 2È£ 94~100

• ÁøÇàµÈ ºñ¼Ò¼¼Æ÷Æó¾ÏȯÀÚ¿¡¼­ Gemcitabine, Cisplatin º¹ÇÕÈ­Çпä¹ýÀÇ Ä¡·áÈ¿°ú

• Gemcitabine/Cisplatin Combination Chemotherapy in Advanced non-Small Cell lung Cancer

• ½ÅÈ£½Ä/Sin HS À°µ¿½Â/±èÈñ±Ô/ÃÖ¹Ù¿ï/ÀÓÇöÁ¤/¹ÚÂùº¹/ÇϽÂÀÎ/¿Áöȣ/ÀåÅ¿ø/Á¤¸¸È«/Yook DS/Kim HK/Choi BU/Lim HJ/Park CB/Ha SI/Ok CH/Jang TW/Jung MH

• °áÇÙ¹×È£Èí±âÁúȯ  2003³â 55±Ç 1È£ 98~106

• Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer

• Cho LC Dimaio JM/Hughes R/Nguyen P/Anderson P/Choy H

• Cancer Research and Treatment  2003³â 35±Ç 5È£ 373~382

• Effect of Combination Chemotherapy with Docetaxel Plus Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer

• Kang HJ Kim MK/Kim YG/Lee JL/Lee KH/Hyun MS/Bae SH/Ryoo HM

• Cancer Research and Treatment  2003³â 35±Ç 4È£ 299~303

• Phase II Study of Gemcitabine and Vinorelbine as Second-Line Chemotherapy in Non-Small Cell Lung Cancer

• Kim YJ Sohn JH/Kim C/Kim YT/Kim HJ/Ahn JB/Kim SK/Chang J/Yoo NC/Kim JH/Cho JY

• Cancer Research and Treatment  2003³â 35±Ç 4È£ 294~298

• Adjuvant Chemotherapy for Completely Resected Non-Small Cell Lung Cancer

• ±è»óÀ§(Kim Sang-We)

• Journal of Lung Cancer  2003³â 2±Ç 1È£ 6~9

• ±¹¼ÒÁøÇ༺ Æó¾ÏȯÀÚ¿¡ ´ëÇÑ Àü½ÅÇ×¾ÏÈ­Çпä¹ýÀÌ ¿îµ¿ºÎÇÏ ½É¡¤Æó±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ : Ãʱ⺯ȭ¸¦ Áß½ÉÀ¸·Î

• Early Response of Cardiopulmonary Exercise Test in Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Systemic Chemotherapy

• ½Å°æö ÀÌ°üÈ£ Á¤ÁøÈ«

• °áÇÙ¹×È£Èí±âÁúȯ  2002³â 53±Ç 4È£ 369~378

• ÁøÇ༺ ºñ¼Ò¼¼Æ÷ Æó¾Ï ȯÀÚ¿¡¼­ Ifosfamide, Cisplatin Etoposide(ICE) º¹ÇÕÈ­Çпä¹ýÀÇ È¿°ú

• Clinical Efficacy of Combination Chemotherapy with Ifosfamide Cisplatin, and Etoposide(ICE) in Advanced Non-Small Cell Lung Cancer

• À̱¸/Gu Lee ±èº´´ö/°­ÈñÁ¤/ÀÌ»ó¿ø/¿ÀÇö¾Æ/¹è¼ºÈ­/ÀÌÀç·Ã/ÀÌ°æÈñ/Çö¸í¼ö/½Å°æö/Á¤ÁøÈ«/ÀÌ°üÈ£/·ùÇö¸ð*/Byung Duk Kim/Hee Jung Kang/Sang Won Lee/Hyun A Oh/Sung Hwa Bae/Jae Lyun Lee/Kyung Hee Lee/Myung Soo Hyun/Kyeong Cheol Shin/Jin Hong Jung/Kwan Ho Lee/Hun Mo Ryu*

• °áÇÙ¹×È£Èí±âÁúȯ  2002³â 52±Ç 4È£ 309~316

• Effect of Vinorelbine, Ifosfamide and Cisplatin Combination Chemotherapy in Stage ¥²-¥³ Non-Small-Cell Lung Cancer

• Hoon Kyo Kim/Young Chul Kim So Young Lee/Hong Joo Cho/Jung A Kim/So Hyang Song/Chi Hong Kim/Hoon Kyo Kim/Meyung Im Ahn/Jin Young You/Sung Whan Kim/Deng Gon Cho/Kyu Do Cho/Jin Hyung Kang

• Cancer Research and Treatment  2002³â 34±Ç 5È£ 352~356

• ºñ¼Ò¼¼Æ÷¼º Æó¾Ï ȯÀÚÀÇ Ç×¾ÏÈ­Çпä¹ýÀ» À§ÇÑ Critical pathway °³¹ß°ú Àû¿ëÈ¿°ú

• Development of a Critical Pathway for the Chemotehrapy of Non-small Cell Lung Cancer Patients and Its Effects

• ÃÖÀÚÀ±(Choi Ja-Yun) Àå±Ý¼º(Jang Keum-Seong) ÃÖÀº¿µ(Chio Eun-Young)

• °£È£ÇàÁ¤ÇÐȸÁö  2002³â 8±Ç 1È£ 85~95

• ºñ¼Ò¼¼Æ÷¾Ï ȯÀÚ¿¡¼­ Docetaxel(Taxotere)°ú Cisplatin º¹ÇÕÈ­ÇÕ¿ä¹ýÀÇ À¯¿ë¼º

• Combination Chemotherapy with Docetaxel(Taxotere) and Cisplatin in patients with Non-Small Cell Lung Cancer

• Á¶Àμº

• ¹ü¼®Çмú³í¹®Áý  2002³â 6±Ç 0È£ 235~242

• Postoperative Adjuvant Chemotherapy and Radiotherapy for Stage II and III Non-Small Cell Lung Cancer (NSCLC)

• ¹ÚÁøÈ«(Park Jin-Hong) ÀÌ»ó¿í(Lee Sang-Wook) ÃÖÀº°æ(Choi Eun-Kyung) Á¤¿ø±Ô(Chung Weon-Kuu) ½Å°æȯ(Shin Kyung-Hwan) ¾È½Âµµ(Ahn Seung-Do) ±èÁ¾ÈÆ(Kim Jong-Hoon) ±è»óÀ§(Kim Sang-We) ¼­Ã¶¿ø(Suh Chul-Won) ÀÌÁ¤½Å(Lee Jung-Shin) ±è¿ì¼º(Kim Woo-Sung) ±èµ¿¼ø(Kim Dong-Soon) ±èµ¿°ü(Kim Dong-Kwan) ¹Ú½ÂÀÏ(Park Seung-Il) ¼Õ±¤Çö(Sohn Kwang-Hyun)

• Journal of Lung Cancer  2002³â 1±Ç 1È£ 34~40

• Recent Trend in The Treatment of Non-Small Cell Lung Cancer

• À̰迵(Lee Kye-Young)

• Journal of Lung Cancer  2002³â 1±Ç 1È£ 1~8

• ÁøÇ༺ ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡¼­ Navelbine, Ifosfamide, Cisplatin º¹ÇÕÇ×¾ÏÈ­Çпä¹ý

• A phase II trial of navelbine, ifosfamide, and cisplatin (NIP) in patients with previously untreated advanced non-small cell lung cancer (NSCLC)

• ±èÅ¿ø/Tae Won Kim ±è»óÈñ/ÃÖ¼ºÁØ/ÃÖÁ¾¼ö/±è»óÀ§/ÃÖÀº°æ/¼­Ã¶¿ø/ÀÌÁ¤½Å/±è¿ì¼º/±èµ¿¼ø/±è¿øµ¿/±è¿ì°Ç/Sang Hee Kim/Sung Jun Choi/Jong Soo Choi/Sang We Kim/Eun Kyung Choi/Cheolwon Suh/Jung Shin Lee/Woo Sung Kim/Dong Soon Kim/Won Dong Kim/Woo Kun Kim

• ´ëÇѳ»°úÇÐȸÁö  2001³â 60±Ç 5È£ 472~478

• Efficacy of Low - dose Paclitaxel and Cisplatin in Patients with Advanced Non - Small Lung Cancer

• ±èº´¼ö/Byung Su Kim ¿Àµµ¿¬/Á¶¿äÇÑ/±èµµ¿¬/±èÁöÇö/À̼¼ÈÆ/ÀÌ´ëÈ£/±èÅÂÀ¯/Çã´ë¼®/¹æ¿µÁÖ/±è³ë°æ/Do Youn Oh/Yo Han Joh/Do Yeun Kim/Jee Hyun Kim/Se Hoon Lee/Dae Ho Lee/Tae You Kim/Dae Seog Heo/Yung Jue Bang/Noe Kyeong Kim

• ´ëÇѾÏÇÐȸÁö  2001³â 33±Ç 6È£ 469~473

• Combination Chemotherapy with Mitomycin C, Vinorelbine, and Cisplatin (MVrP) in Patients with Advanced Non-Small Cell Lung Cancer

• ±èÈƱ¸/Gun Gu Kim ÀÌ°æ¿ø/ÀÌ´ëȯ/ȲÀαÔ/½É±â½Ä/ÀÌ¿ø¼·/ÀÌÁ¾´ö/ÀåÁ¤¼ø/Ȳ¿µ½Ç/ÀÌÁ¾¼®/Gyeong Won Lee/Dae Hwan Lee/In Gyu Hwang/Ki Shik Shim/Won Sup Lee/Jong Deog Lee/Joung Soon Jang/Young Sil Hwang/Jong Seok Lee

• ´ëÇѾÏÇÐȸÁö  2001³â 33±Ç 5È£ 377~384

• Phase II Trial of Vinorelbine and Cisplatin Chemotherapy in Advanced Non - Small Cell Lung Cancer

• Á¶¿äÇÑ/Yo Han Joh ±èÅÂÀ¯/³ªÀÓÀÏ/¿Àµµ¿¬/±èº´¼ö/±èÁöÇö/±èµµ¿¬/À̼¼ÈÆ/À¯Ã¶±Ô/ÀÌÁØÅÃ/±è¿µÈ¯/Çã´ë¼®/¹æ¿µÁÖ/ÇѼº±¸/½É¿µ¼ö/±è³ë°æ/Tae You Kim/Im Il Na/Do Youn Oh/Byung Su Kim/Jee Hyun Kim/Do Yeun Kim/Se Hoon Lee/Chul Gyu Yoo/Choon Taek Lee/Young Whan Kim/Dae Seog Heo/Yung Jue Ban

• ´ëÇѾÏÇÐȸÁö  2001³â 33±Ç 5È£ 373~376

• Á¦ÇѺ´±â ¼Ò¼¼Æ÷ Æó¾ÏÀÇ º¹ÇÕÈ­Çпä¹ý°ú ÈäºÎ ¹æ»ç¼±¿ä¹ýÀÇ µ¿½Ãº´¿ëÄ¡·á¿Í ¼øÂ÷Àû º´¿ëÄ¡·áÀÇ ºñ±³

• Comparison of Concurrent and Sequential Chemotherapy with Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer

• ¹Ú±Ù±Ô °íºÀ°æ

• °è¸íÀÇ´ëÇмúÁö  2001³â 20±Ç 2È£ 154~164

• ºñ¼Ò¼¼Æ÷Æó¾Ï ȯÀÚ¿¡¼­ Cisplatin°ú Vinorelbine º¹ÇÕÈ­Çпä¹ýÀÇ À¯¿ë¼º

• Combination Chemotherapy with Cisplatin and Vinorelbine in Patients with Non-Small-Cell Lung Cancer

• ±è±â¿ø:Kim Kee-Won ¹Ú¼®¿µ:Park Suk-Young/¼­Áö¿ø:Suhr Ji-Won/±è½ÂÁØ:Kim Seung-Joon/¾çµ¿Çå:Yang Dong-Hoen/ÀÌÀºÈñ:Lee Eun-Hee/ÀÌ°æ½Ä:Lee Kyung-Shick

• ´ëÇѾÏÇÐȸÁö  2000³â 32±Ç 5È£ 911~917

• ÁøÇ༺ ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡ ´ëÇÑ Vinorelbine°ú CarboplatinÀÇ Á¦2»ó Àӻ󿬱¸

• A Phase ¥± Study with Vinorelbine and Carboplatin in Patients with Advanced Non-small Cell Lung Cancer

• ±èÁ¾·ü/Jong Lyul Kim ±èºÀ¼®/³ªº´ÁÖ/¼Ò¹ÌÁø/ÀÌÁøÇÑ/Á¤¿À¿µ/À̱ͷ¡/³ë¿ëÈ£/Bong Seog Kim/Byoung Ju Na/Mi Jin So/Jin Han Lee/Oh Young Chung/Gwi Lae Lee/Yong Ho Roh

• ´ëÇѾÏÇÐȸÁö  2000³â 32±Ç 4È£ 690~698

• ÁøÇ༺ ºñ¼Ò¼¼Æ÷ Æó¾Ï¿¡¼­ Vinorelbine, Ifosfamide, Cisplatin 3Á¦ º¹ÇÕÈ­Çпä¹ýÀÇ È¿°ú

• Efficacy of Combination Chemotherapy with Vinorelbine, Ifosfamide, and Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer

• ÀåÈï¹®/Heung Moon Chang ÀÌÁ¤¾Ö/¾ÈÁø¼®/¿ìÀμ÷/¹Ú¿µÀÌ/¼ÕÁö¿õ/À̽ÂÁØ/±èµ¿±Ô/¸ðÀº°æ/¹Ú¸íÀç/ÀÌ¸í±¸/ÇöÀαÔ/Á¤±â¼®/¹Ú¿µ¼®/Jung Ae Lee/Jin Seok Ahn/In Sook Woo/Young Iee Park/Jee Woong Son/Seung Joon Lee/Dong Kyu Kim/Eun Kyung Mo/Myung Jae Park/Myung Goo Lee/In Gyu Hyun/Ki Suck Jung/Y

• ´ëÇѾÏÇÐȸÁö  2000³â 32±Ç 3È£ 612~618

• ÁøÇ༺ ºñ¼Ò¼¼Æ÷ Æó¾Ï¿¡¼­ Etoposide, Ifosfamide, Cisplatin (VIP) º¹ÇÕÈ­Çпä¹ýÀÇ È¿°ú

• Combination Chemotherapy with VP-16, Ifosfamide, and Cisplatin (VIP) in the Advanced Non-Small Cell Lung Cancer

• Á¶¿ë¼±/Yong Seon Cho ±è½Ã¿µ/±èÁ¤Èñ/À±ÈÖÁß/Á¶°æ»ï/Si Young Kim/Jeong Hee Kim/Hwi Joong Yoon/Kyung Sam Cho

• ´ëÇѾÏÇÐȸÁö  2000³â 32±Ç 1È£ 86~92

• ¥²A º´±âÀÇ ºñ¼Ò¼¼Æ÷ Æó¾Ï ȯÀÚ¿¡¼­ ¼úÀü À¯µµÈ­Çпä¹ýÀÇ ÀÓ»óÀû È¿°ú

• Clinical effects of neoadjuvant chemotherapy in stage ¥²A non-small cell lung cancer

• Á¤¼º¼ö/Seong-Su Jeong °­µ¿¿ø/À̱ԽÂ/°íµ¿¼®/¼­Àçö/±è±ÙÈ­/±èÁÖ¿Á/±è¼±¿µ/Dong-Won Kang/Gyu-Seung Lee/Dong-Seok Ko/Jae-Chul Suk/Geun-Hwa Kim/Ju-Ock Kim/Sun-Young Kim

• ´ëÇѳ»°úÇÐȸÁö  1999³â 57±Ç 2È£ 183~190

• ÁøÇ༺ ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡¼­ÀÇ Vinorelbine, Carboplatin, ¹× Ifosfamide 3Á¦ º¹ÇÕÈ­Çпä¹ýÀÇ È¿°ú

• The Effect of Combination Chemotherapy with Vinorelbine, Carboplatin, and Ifosfamide in Patients with Advanced Non-Small Cell Lung Cancer

• ÀÌ¿µ¿ì/Young Woo Lee ·ù¹é·Ä/±èÅÂÀ¯/È«ÇöÁÖ/°ûÁø¿µ/ÀÌ»ó¿ø/°­À±±¸/±èºÀ¼®/¹Ú¿¬Èñ/Baek Yeol Ryoo/Tae You Kim/Hyun Ju Hong/Jin Young Kwag/Sang Won Lee/Yoon Koo Kang/Bong Seog Kim/Yeon Hee Park

• ´ëÇѾÏÇÐȸÁö  1999³â 31±Ç 6È£ 1227~1235

• ÁøÇ༺ ºñ¼Ò¼¼Æ÷ Æó¾Ï¿¡ ´ëÇÑ Cisplatin, Ifosfamide, °æ±¸ Etoposide º¹ÇÕÈ­Çпä¹ýÀÇ È¿°ú

• Clinical Efficacy of Combination Chemotherapy with Cisplatin, Ifosfamide, and Oral Etoposide (PIE) in Advanced Non-Small Cell Lung Cancer

• ±è¿­È«/Yeul Hong Kim ¼­ÀçÈ«/±èº´¼ö/½Å»ó¿ø/½ÉÀçÁ¤/°­°æÈ£/ÃÖ¿µÈ£/±è±¤ÅÃ/±èÁؼ®/Jae Hong Seo/Byung Soo Kim/Sang Won Shin/Jae Jung Shim/Kyung Ho Kang/Young Ho Choi/Kwang Tak Kim/Jun Suk Kim

• ´ëÇѾÏÇÐȸÁö  1999³â 31±Ç 2È£ 297~305

• ÁøÇ༺ ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡ ´ëÇÑ Mitomycin-C, Ifosfamide, Cisplatin º¹ÇÕÈ­ÇÐ ¿ä¹ý

• Mytomycin-C, Ifosfamide and Cisplatin(MIC) Combination Chemotherapy for Advanced Non-Small Cell Lung Cancer

• ¼ÕâÇÐ/Chang Hak Sohn ÁÖ¿µµ·/Young Don Joo

• ÀÎÁ¦ÀÇÇР 1999³â 20±Ç 2È£ 619~625

• ±ÙÄ¡Àû ¸ñÀûÀÇ ÀýÁ¦¼ú ÈÄ ¥±, ¥²A±â ºñ¼Ò¼¼Æ÷Æó¾ÏÀÇ Mitomycin-C, Vinblastine, Cisplatin (MVP) º¹ÇÕÇ×¾ÏÈ­Çпä¹ý°ú ¹æ»ç¼±¿ä¹ýÀÇ º´¿ë Ä¡·á

• Postoperative Sequential Mitomycin-C, Vinblastine, and Cisplatin (MVP) Chemotherapy and Radiotherapy for Resected Stage ¥±-¥²A Non-small Cell Lung Cancer

• ±èÅ¿ø ÀÌÁ¤½Å/Á¤º´ÇÐ/À±È¯Áß/Àå´ë¿µ/ÀÌÁ¦È¯/±è¼º¹è/±è»óÀ§/¼­Ã¶¿ø

• ´ëÇѳ»°úÇÐȸÁö  1998³â 54±Ç 5È£ 607~614

• Á¦ÇѺ´±â ¼Ò¼¼Æ÷Æó¾ÏÀÇ º¹ÇÕÈ­Çпä¹ý°ú ´ÙºÐÇÒ ¹æ»ç¼±¿ä¹ýÀÇ µ¿½Ãº´¿ëÄ¡·áÀÇ È¿°ú

• Concurrent Hypefractionated Radiotherapy with CDDP/VP-16 Chemotherapy in Limited Stage Small Cell Lung Cancer

• ¼ÛÈ«¼® ±èÁøÈñ ±è¿Á¹è

• ´ëÇѾÏÇÐȸÁö  1998³â 30±Ç 5È£ 1053~1060

• ÁøÇ༺ ºñ¼Ò¼¼Æ÷ Æó¾Ï¿¡ ´ëÇÑ Cisplatin, Ifosfamide, Etoposide º¹ÇÕÈ­Çпä¹ý

• Combination Chemotherapy with Cisplatin, Etoposide, and Ifosfamide(PIE) in the Advanced Non-Small Cell Lung Cancer

• ½Å»ó¿ø/Sang Won Shin ±èº´¼ö/½ÉÀçÁ¤/±è¿­È«/°­°æÈ£/ÃÖ¿µÈ£/±è±¤ÅÃ/±èÁؼ®/Byung Soo Kim/Jae Jung Shim/Yeul Hong Kim/Kyung Ho Kang/Young Ho Choi/Kwang Tak Kim/Jun Suk Kim

• ´ëÇѾÏÇÐȸÁö  1998³â 30±Ç 2È£ 225~230

• Á¦ 3±â ºñ¼Ò¼¼Æ÷ Æó¾Ï¿¡¼­ À¯µµ È­ÇÐ ¿ä¹ýÀÇ È¿°ú

• The Efficacy of Induction Chemotherapy in Stage ¥² Non-Small Cell Lung Cancer

• Á¶Èï·¡ ÁÖ¿µµ· ¼ÕâÇÐ ¼Õ½Ââ

• ´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö  1998³â 16±Ç 3È£ 283~289

• ÁøÇ༺ ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡ ´ëÇÑ Cisplatin, Etoposide¿Í Vinblastine(PEV) º¹ÇÕÈ­Çпä¹ýÀÇ Ä¡·á È¿°ú

• Cisplatin, Etoposide and Vinblastine (PIV) Combination Chemotherapy for Advanced Non-Small Cell Lung Cancer

• ±èÀç¼® ±èÈ¿Áø

• µ¿¾ÆÀÇ´ëÇмúÁö  1998³â 10±Ç 1È£ 87~93

• ±¹¼Ò ÁøÇàµÈ ºñ¼Ò¼¼Æ÷ Æó¾Ï¿¡¼­ÀÇ º´ÇÕÄ¡·á¿¡ ´ëÇÑ ¿¬±¸

• The Study of Combined Treatment in Locally Advanced Non - Small Cell Lung Cancer

• ¹Ú»ó±â ±è±ÙÈ­ Á¤¼º¼ö ½Å°æ»ó ±è¾Ö°æ ¼­Áö¿ø ±èÀ缺

• ´ëÇѳ»°úÇÐȸÁö  1997³â 53±Ç 6È£ 795~803

• ÁøÇ༺ ºñ¼Ò¼¼Æ÷ Æó¾Ï¿¡ ´ëÇÑ 5 - Fluorouracil , Vinblastine °ú Cisplatin ( FVP ) ÀÇ º¹ÇÕÈ­Çпä¹ý

• Combination Chemotherapy with 5 - Fluorouracil , Vinblastino and Cisplatin ( FVF ) in thc Advanced Non - Small Cell Lung Cancer

• ÃÖÈ«Áý ±èö¼ö ±è¿¹Èñ ±è¼º·Ï ¾ç¼ºÇö ÃÖ¼öÀü

• ´ëÇѳ»°úÇÐȸÁö  1997³â 53±Ç 1È£ 69~75

• ¼ö¼úÀÌ ºÒ°¡´ÉÇÑ Á¦ ¥²±â ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡¼­ Cisplatin ¹× Etoposide(EP)ÀÇ È­Çпä¹ý°ú ¹æ»ç¼±¿ä¹ýÀÇ º´Çà¿ä¹ý (2»ó Àӻ󿬱¸)

• Phase ¥± Study of Concurrent Chemotherapy with Etoposide and Cisplatin (EP) and Radiation Therapy for Unresectable Stage ¥² Non-small Cell Lung Cancer

• Çã³²Çö ÀÌÃáÅÃ/±èÀçÇÐ/ÀåÀçÁø/³²½Â¸ð/¹Ú¿¬Èñ/·ù¹é·Ä/±èÅÂÀ¯/ÀÓ¿µÇõ

• °áÇÙ¹×È£Èí±âÁúȯ  1997³â 44±Ç 4È£ 776~784

• ±¹¼ÒÁøÇ༺ ºñ¼Ò¼¼Æ÷¼º Æó¾Ï¿¡¼­ 5-FU, Vinblastine ¹× Cisplatin (FVP)ÀÇ ¼ö¼úÀü ¼±Çà È­Çпä¹ýÀÇ È¿°ú

• The Effect of Neoadjuvant Chemotherapy with 5-Fluorouracil(5-FU), Vinblastine and Cisplatin (FVP) for Stage ¥² Non-Small Cell Lung Cancer(NSCLC)

• ¿øÁ¤ÀÏ/Jung Il Won õÁ¾È£/±èÇüÁØ/Á¶¹®¼÷/±èµ¿±Ô/°û¿µÅÂ/±èÁ¤¼÷/ÃÖ¼öÀü/±è¼º·Ï/Jong Ho Chun/Hyeong Jun Kim/Moon Suk Jo/Dong Kyu Kim/Young Tae Kwak/Jung Suk Kim/Soo Jeon Choi/Sung Rok Kim

• ´ëÇѾÏÇÐȸÁö  1997³â 29±Ç 5È£ 807~815

• ¾Ï ȯÀÚ¿¡¼­ º¹ÇÕÈ­Çпä¹ýÁ¦ Åõ¿© ÈÄ °üÂûµÈ ¿°»öüº¯ÀÌ¿¡ ´ëÇÑ ¿¬±¸

• The Study of Chromosomal Aberration in NSCLC Patients which Developed after Administration of Chemotherapeutic Agents

• Â÷¿Õ±â/Wang Ki Cha ÀÌÀç¿ë/½ÅÁØÀç/ÀÌÇö°æ/À¯°èÈ­/¼ÛÀç¼ø/¾ç±¤Èñ/±èÀº½Ç/±èÁ¾¼ø/Jae Yong Lee/Joon Jae Shinn/Hyun Kyung Lee/Kye Hwa Yu/Jae Sun Song/Kwang Hee Yang/Eun Sin Song/Jong Soon Kim

• ´ëÇѾÏÇÐȸÁö  1997³â 29±Ç 3È£ 504~511

• ÁøÇàµÈ ºñ¼Ò¼¼Æ÷¼º Æó¾Ï¿¡ ´ëÇÑ MVPº¹ÇÕÈ­Çпä¹ýÀÇ È¿°ú

• The Effect of Mitomycin-c, Vinblastine, and Cisplatin(NVP) Combined Chemotherapy in Non-Small Cell Lung Cancer

• ±è¿µ¿ì/Young Woo Kim ¹Ú´ÉÈ­/Áö»ó±Ù/ÃÖÇö¹¬/À̽ÅÈ­/À̱ÝÈñ/ÀåÅ¿ø/Á¤¸¸È«/Neung Hwa Park/Sang Keun Ji/Hyun Muck Choi/Sin Hwa Lee/Keum Hee Lee/Tae Won Jang/Maan Hong Jung

• °áÇÙ¹×È£Èí±âÁúȯ  1995³â 42±Ç 1È£ 76~83

• ÁøÇàµÈ ºñ¼Ò¼¼Æ÷ Æó¾Ï¿¡ ´ëÇÑ High-VPP º¹ÇÕÈ­Çпä¹ýÀÇ È¿°ú

• High VPP Combination Chemotherapy for Advanced Non-Small Cell Lung Cancer

• È«¼®Ã¶/Seok Cheol Hong ÇÑÇ¥¼º/ÀÌÁ¾Áø/Á¶ÇØÁ¤/±èÁÖ¿Á/±è¼±¿µ/Pyo Seong Han/Jong Jin Lee/Hai Jeong Cho/Ju Ock Kim/Sun Young Kim

• °áÇÙ¹×È£Èí±âÁúȯ  1993³â 40±Ç 4È£ 367~377

• ºñ¼Ò¼¼Æ÷¼ºÆä¾Ï¿¡¼­ ¹æ»ç¼±Ä¡·á´Üµ¶¿ä¹ý°ú Ç×¾ÏÁ¦ º´ÇÕ¿ä¹ý°úÀÇ Ä¡·á°á°ú ºñ±³

• Therapeutic Results of Radiation Therapy Alone and Combination with Chemotherapy in Non-Small Cell Lung Carcinoma

• ±èÁÖ¸®(Kim Ju-Ree) ¼­Çö¼÷(Suh Hyun-Suk)

• ´ëÇÑÄ¡·á¹æ»ç¼±°úÇÐȸÁö  1993³â 11±Ç 2È£ 303~309

• ÀýÁ¦ ºÒ°¡´ÉÇÑ Á¦3±â ºñ¼Ò¼¼Æ÷ Æä¾ÏÀÇ MVP º¹ÇÔ Ç׾Ͽä¹ý°ú ´ÙºÐÇÒ ¹æ»ç¼± Ä¡·á-Ãß°¡ Ç׾Ͽä¹ý¿¡ ´ëÇÑ ÀÓÀÇ ¼±Åà -

• Hyperfractionated Radiotherapy Following Induction Chemotherapy for Stage ¥² Non-Small Cell Lung Cancer-Random iced for Adjuvant Chemotherapy vs. Observation-

• ÃÖÀº°æ(Choi Eun-Kyung) ÀåÇý¼÷(Chang Hye-Sook) ¾È½Âµµ(Ahn Seung-Do) ¾ç±¤¸ð(Yang Gwang-Mo) ¼­Ã¶¿ø(Suh Chul-Won) À̱ÔÇü(Lee Kyoo-Hyung) ÀÌÁ¤½Å(Lee Jung-Shin) ±è»óÈñ(Kim Sang-Hee) °íÀ±¼®(Koh Youn-Suck) ±è¿ì¼º(Kim Woo-Sung) ±è¿øµ¿(Kim Won-Dong) ¼Û±º½Ä(Song Koun-Sik) ¼Õ±¤Çö(Sohn Kwang-Hyun)

• ´ëÇÑÄ¡·á¹æ»ç¼±°úÇÐȸÁö  1993³â 11±Ç 2È£ 295~301

• Á¦4±â ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡ ´ëÇÑ Cisplatin,Ifosfamide,Bischlorethy Nitrosurea 3Á¦ º¹ÇÕ Ç×¾ÏÈ­Çпä¹ý

• Cisplatin,Ifosfamide and Bischlorethyl Nitrosourea Combination Chemotherapy for the Treatment of Disseminated Non Small Cell Lung Carcinoma

• Kim, Chul Soo/±èö¼ö Kim, Dong Soon/Kim, Re Hwe/±èµ¿¼ø/±è¿¹Èñ

• ÀÎÁ¦ÀÇÇР 1991³â 12±Ç 1È£ 37~43

• Á¦ 3±âÀÇ ÁøÇ༺ ºñ¼Ò¼¼Æ÷ Æó¾Ï¿¡¼­ÀÇ MVP º¹ÇÕ Ç×¾Ï ¿ë¹ý°ú ´ÙºÐÇÒ ¹æ»ç¼± Ä¡·á - Ãß°¡ Ç×¾Ï ¿ä¹ý¿¡ ´ëÇÑ ÀÓÀÇ ¼±ÅÃ-

• MVP Chemotherpy and Hyperfractionated Radiotherapy for Stage ¥² Unresectable Non-Small Cell Lung Cancer

• ÃÖÀº°æ(Choi Eun-Kyung) À̱ÔÇü(Lee Kyoo-Hyung) ÀÌÁ¤½Å(Lee Jung-Shin) ±è»óÈñ(Kim Sang-Hee) ÀåÇý¼÷(Chang Hye-Sook) ±è¿ì¼º(Kim Woo-Sung) ±è¿øµ¿(Kim Won-Dong) ¼Õ±¤Çö(Sohn Kwang-Hyun) ¼­Ã¶¿ø(Suh Chul-Won) ÃÖöÁØ(Choi Chul-Joon) °íÀ±¼®(Koh Youn-Suck) ±è»ïÇö(Kim Sam-Hyun)

• ´ëÇÑÄ¡·á¹æ»ç¼±°úÇÐȸÁö  1991³â 9±Ç 2È£ 215~219